<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Public Health</journal-id><journal-id journal-id-type="iso-abbrev">Front Public Health</journal-id><journal-id journal-id-type="pmc-domain-id">2277</journal-id><journal-id journal-id-type="pmc-domain">frontpubhealth</journal-id><journal-id journal-id-type="publisher-id">Front. Public Health</journal-id><journal-title-group><journal-title>Frontiers in Public Health</journal-title></journal-title-group><issn pub-type="epub">2296-2565</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10721974</article-id><article-id pub-id-type="pmcid-ver">PMC10721974.1</article-id><article-id pub-id-type="pmcaid">10721974</article-id><article-id pub-id-type="pmcaiid">10721974</article-id><article-id pub-id-type="pmid">38106902</article-id><article-id pub-id-type="doi">10.3389/fpubh.2023.1269209</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Public Health</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Screening of hepatitis B and C viral infection, recognition of risk factors, and immunization of patients against hepatitis B virus: a module developed for effective hepatitis control</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name name-style="western"><surname>Ejaz</surname><given-names initials="S">Samina</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref><xref rid="fn0001" ref-type="author-notes">
<sup>&#8224;</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/516324/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Abdullah</surname><given-names initials="I">Iqra</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="fn0001" ref-type="author-notes">
<sup>&#8224;</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/2553930/overview"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/software/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Malik</surname><given-names initials="WN">Waqas Nazir</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="fn0001" ref-type="author-notes">
<sup>&#8224;</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Anjum</surname><given-names initials="S">Shazia</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ashraf</surname><given-names initials="M">Muhammad</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/2215902/overview"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Akhtar</surname><given-names initials="N">Naveed</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Khan</surname><given-names initials="A">Aurangzeb</given-names></name><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hameed</surname><given-names initials="Y">Yasir</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/1440790/overview"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Usman</surname><given-names initials="M">Muhammad</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cheema</surname><given-names initials="U">Usman</given-names></name><xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sidiq</surname><given-names initials="S">Safeena</given-names></name><xref rid="aff7" ref-type="aff">
<sup>7</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Biochemistry, Institute of Biochemistry, Biotechnology and Bioinformatics (IBBB), The Islamia University of Bahawalpur</institution>, <addr-line>Bahawalpur</addr-line>, <country>Pakistan</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Biotechnology, Institute of Biochemistry, Biotechnology and Bioinformatics (IBBB), The Islamia University of Bahawalpur</institution>, <addr-line>Bahawalpur</addr-line>, <country>Pakistan</country></aff><aff id="aff3"><sup>3</sup><institution>Institute of Chemistry, The Islamia University of Bahawalpur</institution>, <addr-line>Bahawalpur</addr-line>, <country>Pakistan</country></aff><aff id="aff4"><sup>4</sup><institution>Department of Pharmaceutics, Faculty of Pharmacy, The Islamia University of Bahawalpur</institution>, <addr-line>Bahawalpur</addr-line>, <country>Pakistan</country></aff><aff id="aff5"><sup>5</sup><institution>District Head Quarter Hospital</institution>, <addr-line>Bahawalpur</addr-line>, <country>Pakistan</country></aff><aff id="aff6"><sup>6</sup><institution>Medical Division, The Islamia University of Bahawalpur</institution>, <addr-line>Bahawalpur</addr-line>, <country>Pakistan</country></aff><aff id="aff7"><sup>7</sup><institution>Women Health Care Center and Maternity Home (WHCC&amp;MH), The Islamia University of Bahawalpur</institution>, <addr-line>Bahawalpur</addr-line>, <country>Pakistan</country></aff><author-notes><fn fn-type="edited-by" id="fn0002"><p>Edited by: Jian Wu, Suzhou Municipal Hospital, China</p></fn><fn fn-type="edited-by" id="fn0003"><p>Reviewed by: Lejla &#268;alki&#263;, VITEZ University, Bosnia and Herzegovina; Edmond Puca, Service of Infection Diseases University Hospital Center, Albania; Guilherme Campos, Faculdade de Medicina de S&#227;o Jos&#233; do Rio Preto, Brazil; Ulrich Vickos, Bambino Ges&#249; Children&#8217;s Hospital (IRCCS), Italy</p></fn><corresp id="c001">*Correspondence: Samina Ejaz, <email>samina.ejazsyed@iub.edu.pk</email>; <email>saminaejazsyed@yahoo.com</email></corresp><fn fn-type="equal" id="fn0001"><p><sup>&#8224;</sup>These authors have contributed equally to this work and share first authorship</p></fn></author-notes><pub-date pub-type="epub"><day>23</day><month>11</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>11</volume><issue-id pub-id-type="pmc-issue-id">427737</issue-id><elocation-id>1269209</elocation-id><history><date date-type="received"><day>29</day><month>7</month><year>2023</year></date><date date-type="accepted"><day>06</day><month>10</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>23</day><month>11</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>15</day><month>12</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-01-29 03:25:23.260"><day>29</day><month>01</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2023 Ejaz, Abdullah, Malik, Anjum, Ashraf, Akhtar, Khan, Hameed, Usman, Cheema and Sidiq.</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Ejaz, Abdullah, Malik, Anjum, Ashraf, Akhtar, Khan, Hameed, Usman, Cheema and Sidiq.</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fpubh-11-1269209.pdf"/><abstract><sec id="sec1"><title>Introduction</title><p>The continually increasing incidence of hepatitis, a worldwide health issue, in Pakistan, has highlighted the need to investigate the epidemiology factors and implement preventive measures accordingly. The purpose of this study was to scrutinize the prevalent and significantly associated risk factors of hepatitis in students and employees, screening them for hepatitis B and C virus and vaccinating them against HBV to make IUB hepatitis free.</p></sec><sec id="sec2"><title>Methodology</title><p>A total of 12,912 participants including students (<italic toggle="yes">n</italic>&#8201;=&#8201;10,948) and employees (<italic toggle="yes">n</italic>&#8201;=&#8201;1964) were screened for HBV and HCV via immunochromatographic test. Hepatitis- positive participants&#8217; blood samples were further tested and viral load was estimated by quantitative PCR. All the hepatitis-negative participants were vaccinated against HBV. The demographic and risk factors-related data were collected using the questionnaire. Statistical analysis (Chi-square test and bivariate regression analysis) was performed using SPSS software to explore any association between risk factors and hepatitis.</p></sec><sec id="sec3"><title>Results</title><p>Results indicated that 662/12912 participants (students&#8201;=&#8201;478/10,948, employees&#8201;=&#8201;184/1,964) tested positive for hepatitis. Among them, HCV was observed to be more prevalent than HBV among the study participants, employees, and students, and viral count was low in both HBV and HCV-infected participants. However, men were more affected than women. The studied risk factors represented higher frequency among hepatitis-positive participants relative to the hepatitis-negative participants. The Chi-square test revealed that students&#8217; gender, history of hepatitis in the family and relatives, dental treatment, sharing cosmetics and shaving blades were significant (<italic toggle="yes">p</italic>&#8201;&gt;&#8201;0.005) risk factors of hepatitis while in the employees group surgery and age were significant. Moreover, the reused of syringes was found to be associated with hepatitis in both groups. The bivariate analysis helped to identify various new risk factors which were independently, either positively or negatively, associated with hepatitis.</p></sec><sec id="sec4"><title>Discussion</title><p>Our study enabled us to recognize different risk factors of hepatitis among the target population. The information thus generated can be usefully applied in planning hepatitis awareness, targeted screening, and effective control programs for other target populations. In general, this module can be further utilized for any other disease.</p></sec></abstract><kwd-group><kwd>Hepatitis B virus</kwd><kwd>Hepatitis C virus</kwd><kwd>risk factors</kwd><kwd>screening</kwd><kwd>immunization and prevention</kwd></kwd-group><funding-group><funding-statement>The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.</funding-statement></funding-group><counts><fig-count count="6"/><table-count count="4"/><equation-count count="0"/><ref-count count="34"/><page-count count="13"/><word-count count="8972"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Infectious Diseases: Epidemiology and Prevention</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec5"><label>1</label><title>Introduction</title><p>Viral hepatitis is ranked the 8th leading cause of death around the world (<xref rid="ref1" ref-type="bibr">1</xref>). This disease caused approximately 1.1 million mortalities around the globe in the year 2021 (<xref rid="ref2" ref-type="bibr">2</xref>). Currently, a total of 257 million individuals (both men and women) are suffering from chronic hepatitis B and 71 million individuals (both men and women) are suffering from hepatitis C (<xref rid="ref3" ref-type="bibr">3</xref>). If hepatitis keeps spreading at this rate, approximately 20 million deaths are expected to occur during 2020&#8211;2030 (<xref rid="ref1" ref-type="bibr">1</xref>).</p><p>Hepatitis B virus is a member of the <italic toggle="yes">Hepadnaviridae</italic> family of animal viruses and carries a double-stranded genome 3.2&#8201;kb in length, while hepatitis C virus is classified in the <italic toggle="yes">Hepacivirus</italic> genus of the <italic toggle="yes">Flaviviridae</italic> family, and its genome is a positive-stranded RNA 9.6&#8201;kb in length (<xref rid="ref4" ref-type="bibr">4</xref>). In terms of the global burden, Pakistan and Egypt are currently bearing an estimated 80% of the total hepatitis burden (<xref rid="ref5" ref-type="bibr">5</xref>). Moreover, in Pakistan, currently, 12 million individuals (both men and women) are infected with hepatitis B or C (<xref rid="ref6" ref-type="bibr">6</xref>) and this incidence is expected to increase in the coming years (<xref rid="ref6" ref-type="bibr">6</xref>). Hepatitis disease is also known as a silent killer disease because most of the patients suffering from this disease remain undiagnosed and untreated for a long time before developing serious health complications (<xref rid="ref7" ref-type="bibr">7</xref>). The major route of transmission of HBV is sexual contact, perinatal transmission, or horizontal transmission (<xref rid="ref8" ref-type="bibr">8</xref>) while of HCV is infected blood (<xref rid="ref9" ref-type="bibr">9</xref>).</p><p>Worldwide, the main risk factors for transmitting hepatitis B or C viruses are sexual contact, surgical procedures, skin tattoos, hemodialysis, being immune-compromised, household contact (<xref rid="ref10" ref-type="bibr">10</xref>), reuse of syringes, surgery with contaminated instruments, blood transfusion, therapeutic injections, the use of unsterilized invasive medical devices, hospitalization, and sharing of razors (<xref rid="ref11" ref-type="bibr">11</xref>). A few selective population groups are highly prone to be affected by hepatitis B and C, for example, drug users and thalassemia patients have more chances of getting hepatitis B and C infections (<xref rid="ref12" ref-type="bibr">12</xref>).</p><p>In Pakistan, the identified major risk factors of HCV are having a HCV-infected mother, male sex, intravenous drug use, hospitalization, contaminated surgical equipment, circumcision by a barber, dental treatment (<xref rid="ref13" ref-type="bibr">13</xref>) thalassemia, hemophilia, and blood transfusion (<xref rid="ref14" ref-type="bibr">14</xref>). For HBV, the main factors are having a HBV-infected mother and circumcision by a barber (<xref rid="ref13" ref-type="bibr">13</xref>), blood transfusion, reused syringes, surgery, hospitalization, shaving at a barber, needle injury, intravenous drug abuse, and sexual contact (<xref rid="ref15" ref-type="bibr">15</xref>).</p><p>It is a fact that new cases of hepatitis infection are reduced in high-income countries (<xref rid="ref16" ref-type="bibr">16</xref>), and the cases of this infection in many other low and middle-income countries, including Pakistan, are rising at a constant rate (<xref rid="ref17" ref-type="bibr">17</xref>). Keeping in view the alarming situation regarding hepatitis infection, the government of Pakistan launched a national hepatitis sentry site observation system in June 2010 (Centers for Disease Control and Prevention 2011, CDC) to deal with the disease. However, due to the lack of proper infrastructure and the availability of facilities, this public health system was only limited to the regional capitals and Islamabad territory (<xref rid="ref18" ref-type="bibr">18</xref>). Moreover, this program also restricted screening seropositivity in general people (<xref rid="ref18" ref-type="bibr">18</xref>), excluding the high-risk groups like students studying in public sector universities. University students have not always been assumed as a priority while designing preventive and treatment policies because students are assumed to be healthier than others. However, during this time, students often adopt unhealthy lifestyles and habits, for example, eating poor foodstuffs, taking little rest, physical inactivity, smoking cigarettes, drinking alcohol, and drug abuse, which can badly affect their health in the short- or long-term (<xref rid="ref19" ref-type="bibr">19</xref>, <xref rid="ref20" ref-type="bibr">20</xref>). Previous studies have highlighted that the lack of awareness among university students is one of the major Barrier to HCV treatment (<xref rid="ref21" ref-type="bibr">21</xref>, <xref rid="ref22" ref-type="bibr">22</xref>), and early diagnosis can be a key milestone in hepatitis management (<xref rid="ref23" ref-type="bibr">23</xref>).</p><p>Keeping in view the high prevalence of hepatitis disease in the Pakistani population, it was assumed that we could raise awareness about this disease in society by educating the students enrolled in Pakistani public sector universities. Therefore, the Vice Chancellor (VC) of IUB, Engineer Prof. Dr. Athar Mehboob, in collaboration with the &#8216;Hepatitis Control Program&#8217; of the Health Department, Government of Punjab, Pakistan decided to launch a hepatitis control program at IUB. The purpose of this program was to raise awareness about hepatitis among the students and employees of IUB, screening them for hepatitis, vaccinating healthy individuals, and providing a facility of therapy for hepatitis-positive participants. Moreover, the program aimed to identify risk factors associated with the high prevalence of hepatitis in Pakistani students and employees. The ultimate goal of this program was to develop a module for the implementation of effective hepatitis control and ensure the status of IUB as a hepatitis-free zone. The vision of the hepatitis-free zone was to ascertain healthy youth which may finally lead to a healthy nation.</p></sec><sec sec-type="methods" id="sec6"><label>2</label><title>Methods</title><sec id="sec7"><label>2.1</label><title>Program description and setting</title><p>The present study was initiated in November 2019 and completed in February 2020. This study was designed as a joint venture of the District Health Authority (DHA), Bahawalpur, and IUB as an extension of the Hepatitis Prevention and Control Program (HPCP). The project was named &#8220;Hepatitis Free University-The Islamia University of Bahawalpur.&#8221; The work strategy is outlined in <xref rid="fig1" ref-type="fig">Figure 1</xref>.</p><fig position="float" id="fig1" orientation="portrait"><label>Figure 1</label><caption><p>Overall work strategy. Represents the workflow of hepatitis control program including approval of program, sampling, data collection, and screening.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fpubh-11-1269209-g001.jpg"/></fig></sec><sec id="sec8"><label>2.2</label><title>Ethics approval</title><p>The presented study was approved by the IUB review board / ethical committee and was conducted following the guidelines of the Helsinki Model Convention 1992. All subjects were enrolled in the study after obtaining written informed consent individually from every participant, either student or employee.</p></sec><sec id="sec9"><label>2.3</label><title>Study design and planning</title><p>Different committees supervised by the focal person were constituted by the VC, IUB, and DHA, Bahawalpur for the smooth implementation of the program. The meetings of committee members were held regularly, and minutes of the meetings were written and circulated among the members for record-keeping and follow-up plans. The detailed plan for the implementation of this project was outlined with the consensus of all committee members.</p><sec id="sec10"><label>2.3.1</label><title>Public awareness plan</title><p>An extensive public awareness plan was chalked out comprising three layers. First, banners with the slogan &#8220;Hepatitis-Free University&#8221; were displayed all over the university and on the official social media pages of IUB and DHA. The DHA and IUB Medical &amp; Health Division distributed brochures/awareness literature published by &#8216;Hepatitis &amp; Infection Control Program Punjab&#8217; among IUB students and employees. In all departments, the relevant literature was displayed on the noticeboard to ensure the passage of information to all stakeholders. Information on the &#8220;Hepatitis-Free University Program&#8221; was published in various local and national level newspapers by the PRO office of IUB. Various seminars were arranged 1&#8201;week prior to the execution of the plan at the faculty level and, finally, a mega seminar was arranged to sensitize the public regarding hepatitis-associated health hazards. Finally, SMS alerts were sent to the contact numbers of all students and employees to convey messages regarding the hepatitis-free university campaign.</p></sec><sec id="sec11"><label>2.3.2</label><title>Policy for compliance</title><p>For 100% compliance, every student and employee was instructed to get screened and vaccinated as per convenience at the IUB screening camp or Punjab health care units/hospitals. It was notified that none of the students would be allowed to attend classes or participate in any activity without presenting their vaccination card. Similarly, employees were directed to comply with the orders to get due financial benefits.</p></sec><sec id="sec12"><label>2.3.3</label><title>Scheduling of subjects for screening</title><p>Information about employees and students was obtained from the respective administrative offices, i.e., registrar&#8217;s office and respective departments. Specific days were assigned for each faculty&#8217;s students, teaching, and non-teaching staff for screening and vaccination. All the stakeholders were informed regarding the schedule and, according to the plan, participants were screened and vaccinated. For smooth implementation, chairpersons were directed to accompany students and staff on the screening camp and ensure their availability. To ensure 100% compliance, SMS alerts were sent to all scheduled subjects and all correspondence to chairpersons/heads was done through corresponding faculty deans and the registrar&#8217;s office, respectively.</p></sec></sec><sec id="sec13"><label>2.4</label><title>Data collection and medical team</title><p>A medical team was recruited from the Health Department, Government of Punjab, and IUB Medical &amp; Health Division for the screening and vaccination of participants. Dr. Usman Cheema, Senior Medical Officer (SMO) from the IUB medical division, and Dr. Aurangzeb, from District Head Quarters (DHQ) Hospital Bahawalpur, supervised the screening procedure, validated diagnostic/laboratory reports, and recommended vaccination. Moreover, Dr. Usman Cheema is responsible for supervising the treatment of hepatitis-positive patients.</p><p>For data collection, a team of volunteer students of BS Biochemistry and Biotechnology 6th semester (Session 2017&#8211;2021) and of the 8th semester (Session Spring 2016&#8211;2020) was trained.</p></sec><sec id="sec14"><label>2.5</label><title>Hepatitis screening</title><p>For hepatitis screening, a 26-day screening camp from 31st December 2019 to 25th January 2020 was held at the university. The screening camp was arranged at the university auditorium for the initial 20&#8201;days. Next, camps were held at the faculty level for 6&#8201;days. All the participants were recruited for screening according to their schedule during said duration (31st December 2019 to 25th January 2020).</p><p>In total, 12,912 participants including students (10,948) and employees (1964) were screened for HBsAg and anti-HCV. The Monolisa HBsAg Plus kit was used to screen hepatitis B, in human serum or plasma. The Hepatitis C screening was done with a Diasorian S. A kit.</p></sec><sec id="sec15"><label>2.6</label><title>Immunization</title><p>Non-reactive participants were immunized for hepatitis B virus. The first dose of the vaccine was given on the spot, the second dose after a month, and the third after 6&#8201;months. The vaccinations were completed at the hepatitis and infection control sentinel site established in IUB medical division BJ campus hospital.</p></sec><sec id="sec16"><label>2.7</label><title>PCR confirmation</title><p>Blood samples from HBV, HCV, or both positive participants were taken for confirmation of viral infection and viral load detection by qPCR. The samples were shifted to the central PCR section of the pathology laboratory in Bahawal Victoria Hospital (BVH), Bahawalpur for PCR confirmation. A viral count of &gt;8,00,000&#8201;IU/mL was recorded as a high viral load, &lt;8,00,000&#8201;IU/mL to be a low viral load, and&#8201;&lt;&#8201;20&#8201;IU/mL equals a very low viral load detected among hepatitis-positive participants.</p></sec><sec id="sec17"><label>2.8</label><title>Medication</title><p>The affected participants (having viral load) after the qPCR confirmation were called for consultation at the hepatitis clinic of the university&#8217;s hospital and Bahawal Vitoria Hospital Bahawalpur. The hepatitis-positive participants were given medicine according to the severity of the disease and the burden of viral load. The hepatitis-positive participants were followed up until they were cured to minimize complications, if any.</p></sec><sec id="sec18"><label>2.9</label><title>Data collection</title><p>A questionnaire was designed under the supervision of the scientific committee. It consists of three segments: (i) Demographic Information, (ii) Medical History, and (iii) Behavioral parameters. To make the data collection smooth and easy, the questionnaire was made available through an online portal. Each entry was saved at the local server at the university with the help of information technology (IT) experts of the university which ensured access to information of each participant during and after data collection. This helped in identifying individual participants. The screening test results and qPCR results were obtained from the team of DHA, Bahawalpur.</p></sec><sec id="sec19"><label>2.10</label><title>Studied variables</title><p>In the described study we have evaluated the following variables. Socioeconomic and demographic-related variables included Gender, Age, Income, Education, Marital status, Household contacts, Hepatitis history in relatives, Marriage trend, and Mother-infected with hepatitis. Medical-related variables were Blood group, Blood transfusion, Facial treatment, Surgery, Drug abuse/addiction, and already being vaccinated against HBV. Behavioral-related variables included smoking, reused syringes, and sharing shaving razors/machines, towels, and cosmetics.</p><p>Due to ethical conditions, some important worldwide known significant risk factors of HBV/HCV were not included in the present study, including transmission (promiscuity and homosexuality), alcohol consumption, and tattoos, as these are forbidden and are unlawful in our religion Islam.</p></sec><sec id="sec20"><label>2.11</label><title>Statistical data analysis</title><p>The data was split into two categories, employees and students, who were then processed separately for statistical analysis. The Statistical Package of Social Sciences (SPSS) software version 22 was used for the descriptive and bivariate statistics. For prevalence, the frequency of each parameter was calculated separately for the student and employee groups. The chi-square (<italic toggle="yes">X</italic><sup>2</sup>) test was performed to determine the association between each risk factor (qualitative) and hepatitis in both groups. For <italic toggle="yes">X</italic><sup>2</sup>, the alpha criterion was adjusted at 0.05 (95% confidence interval (CI)) and a <italic toggle="yes">p</italic>-value&lt;0.05 was considered significant. For binary logistic regression &#8220;Multicollinearity assumptions test&#8221; was performed. Binary logistic regression using 95% CI (alpha criterion&#8201;=&#8201;0.05) was employed to estimate the independent risk factors of hepatitis and the extent of the relationship between them in terms of the odd ratio of probability. The reference category was chosen to be the first.</p></sec></sec><sec sec-type="results" id="sec21"><label>3</label><title>Results</title><sec id="sec22"><label>3.1</label><title>Success of execution plan</title><p>We have achieved the target of 100% screening and vaccination in two steps. At first in the mega camp (at university&#8217;s main auditorium), 60% of the IUB students and employees were screened and vaccinated against HBV. While for the remaining 40%, camps at the faculty level were arranged.</p></sec><sec id="sec23"><label>3.2</label><title>Socio-economic and demographic details of participants</title><p>Overall, 662/12912 (5.12%) subjects tested positive for hepatitis viral infection. Among them, 478/10,948 (4.3%) (male&#8201;=&#8201;346/5539 (6.24%), female&#8201;=&#8201;132/5409 (2.4%)) were student participants, while 184/1,964, i.e., 9.36% [male&#8201;=&#8201;121/1216 (9.95%), female&#8201;=&#8201;63/748 (8.34%)] were employees. Most hepatitis-positive students (59.21%) and hepatitis-negative students (85.58%) lie in the range of 16&#8211;25&#8201;years of age. While the higher ratio of hepatitis-positive and hepatitis-negative employees were noted to be in the 26&#8211;40&#8201;year age group (i.e., 30 and 37%, respectively). Most of the hepatitis-positive students (44.98%) and hepatitis-negative students (65.38%) were graduated (16&#8201;years of education). Among the employees, the majority, 30% (Hepatitis-positive) and 29% (Hepatitis-negative) of participants, had primary education (5&#8201;years of education). The highest frequency (32.62%) of hepatitis-positive students and 45.67% of hepatitis-negative students belong to the middle income (below 50,000) class and 26% of hepatitis-positive employees and 32% of hepatitis-negative employees were from low-income class. In our study, a large number (60.67%) of hepatitis-positive student participants and 91.41% of hepatitis-negative participants (students) were non-married while 6% of hepatitis-positive employees and 65% of hepatitis negative employees were married. Among them, an intrafamily marriage trend was observed in 68% of hepatitis-positive students participants and 53% of hepatitis-negative employees, while 25% of hepatitis-positive employee and 34% of hepatitis-negative employee reported interfamily marriages. Among students 4.8% of students of mothers who are hepatitis positive were also infected with hepatitis while 2.71% of students with hepatitis negative mothers were infected. Among employees, 1.08% with hepatitis positive mothers and 1.09% with hepatitis negative mothers were hepatitis positive (<xref rid="tab1" ref-type="table">Table 1</xref>). The infection in any family member factor was found in only 17% of patients, 8% of hepatitis negative students, 7% of hepatitis positive employees, and 4% of hepatitis-negative employees. The Fisher exact test for household contact of hepatitis in students equals 0.01 and thus was associated with hepatitis. In 2% of hepatitis-positive student participants, infection history in their relatives was noted with an <italic toggle="yes">X<sup>2</sup></italic> value of 8.6, <italic toggle="yes">p</italic>-value 0.00. The association of other socioeconomic factors with hepatitis has been shown in <xref rid="SM1" ref-type="supplementary-material">Supplementary Table S3</xref>.</p><table-wrap position="float" id="tab1" orientation="portrait"><label>Table 1</label><caption><p>Frequency of demographic and socioeconomic parameters in hepatitis-negative and -positive participants.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="2" colspan="1">Sr. No.</th><th align="left" valign="top" rowspan="2" colspan="1">Factors</th><th align="left" valign="top" rowspan="2" colspan="1">Response</th><th align="center" valign="top" colspan="2" rowspan="1">Hepatitis negative students</th><th align="center" valign="top" colspan="2" rowspan="1">Hepatitis positive students</th><th align="center" valign="top" rowspan="2" colspan="1">Sr. No.</th><th align="left" valign="top" rowspan="2" colspan="1">Factors</th><th align="left" valign="top" rowspan="2" colspan="1">Response</th><th align="center" valign="top" colspan="2" rowspan="1">Hepatitis negative employees</th><th align="center" valign="top" colspan="2" rowspan="1">Hepatitis positive employees</th></tr><tr><th align="center" valign="top" rowspan="1" colspan="1">Numbers</th><th align="center" valign="top" rowspan="1" colspan="1">Frequency</th><th align="center" valign="top" rowspan="1" colspan="1">Numbers</th><th align="center" valign="top" rowspan="1" colspan="1">Frequency</th><th align="center" valign="top" rowspan="1" colspan="1">Numbers</th><th align="center" valign="top" rowspan="1" colspan="1">Frequency</th><th align="center" valign="top" rowspan="1" colspan="1">Number</th><th align="center" valign="top" rowspan="1" colspan="1">Frequency</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="2" colspan="1">1</td><td align="left" valign="top" rowspan="2" colspan="1">Gender</td><td align="left" valign="top" rowspan="1" colspan="1">Male</td><td align="center" valign="top" rowspan="1" colspan="1">5,193</td><td align="center" valign="top" rowspan="1" colspan="1">49.50%</td><td align="center" valign="top" rowspan="1" colspan="1">346</td><td align="center" valign="top" rowspan="1" colspan="1">72.38%</td><td align="center" valign="top" rowspan="2" colspan="1">1</td><td align="left" valign="top" rowspan="2" colspan="1">Gender</td><td align="left" valign="top" rowspan="1" colspan="1">Male</td><td align="center" valign="top" rowspan="1" colspan="1">1,095</td><td align="center" valign="top" rowspan="1" colspan="1">61.50%</td><td align="center" valign="top" rowspan="1" colspan="1">121</td><td align="center" valign="top" rowspan="1" colspan="1">65.70%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Female</td><td align="center" valign="top" rowspan="1" colspan="1">5,277</td><td align="center" valign="top" rowspan="1" colspan="1">50.40%</td><td align="center" valign="top" rowspan="1" colspan="1">132</td><td align="center" valign="top" rowspan="1" colspan="1">17.64%</td><td align="left" valign="top" rowspan="1" colspan="1">Female</td><td align="center" valign="top" rowspan="1" colspan="1">685</td><td align="center" valign="top" rowspan="1" colspan="1">62.50%</td><td align="center" valign="top" rowspan="1" colspan="1">63</td><td align="center" valign="top" rowspan="1" colspan="1">34.20%</td></tr><tr><td align="left" valign="top" rowspan="5" colspan="1">2</td><td align="left" valign="top" rowspan="5" colspan="1">Age</td><td align="left" valign="top" rowspan="1" colspan="1">16&#8211;25</td><td align="center" valign="top" rowspan="1" colspan="1">8,960</td><td align="center" valign="top" rowspan="1" colspan="1">85.58%</td><td align="center" valign="top" rowspan="1" colspan="1">283</td><td align="center" valign="top" rowspan="1" colspan="1">59.21%</td><td align="center" valign="top" rowspan="5" colspan="1">2</td><td align="left" valign="top" rowspan="5" colspan="1">Age</td><td align="left" valign="top" rowspan="1" colspan="1">16&#8211;25</td><td align="center" valign="top" rowspan="1" colspan="1">485</td><td align="center" valign="top" rowspan="1" colspan="1">27%</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">9%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">26&#8211;40</td><td align="center" valign="top" rowspan="1" colspan="1">871</td><td align="center" valign="top" rowspan="1" colspan="1">8.32%</td><td align="center" valign="top" rowspan="1" colspan="1">36</td><td align="center" valign="top" rowspan="1" colspan="1">7.53%</td><td align="left" valign="top" rowspan="1" colspan="1">26&#8211;40</td><td align="center" valign="top" rowspan="1" colspan="1">662</td><td align="center" valign="top" rowspan="1" colspan="1">37%</td><td align="center" valign="top" rowspan="1" colspan="1">55</td><td align="center" valign="top" rowspan="1" colspan="1">30%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">41&#8211;50</td><td align="center" valign="top" rowspan="1" colspan="1">180</td><td align="center" valign="top" rowspan="1" colspan="1">1.72%</td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">2.30%</td><td align="left" valign="top" rowspan="1" colspan="1">41&#8211;50</td><td align="center" valign="top" rowspan="1" colspan="1">298</td><td align="center" valign="top" rowspan="1" colspan="1">17%</td><td align="center" valign="top" rowspan="1" colspan="1">31</td><td align="center" valign="top" rowspan="1" colspan="1">17%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Above 50</td><td align="center" valign="top" rowspan="1" colspan="1">85</td><td align="center" valign="top" rowspan="1" colspan="1">1%</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">1%</td><td align="left" valign="top" rowspan="1" colspan="1">Above 50</td><td align="center" valign="top" rowspan="1" colspan="1">218</td><td align="center" valign="top" rowspan="1" colspan="1">12%</td><td align="center" valign="top" rowspan="1" colspan="1">23</td><td align="center" valign="top" rowspan="1" colspan="1">12%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Not Answered</td><td align="center" valign="top" rowspan="1" colspan="1">374</td><td align="center" valign="top" rowspan="1" colspan="1">4%</td><td align="center" valign="top" rowspan="1" colspan="1">145</td><td align="center" valign="top" rowspan="1" colspan="1">30%</td><td align="left" valign="top" rowspan="1" colspan="1">Not Answered</td><td align="center" valign="top" rowspan="1" colspan="1">117</td><td align="center" valign="top" rowspan="1" colspan="1">7%</td><td align="center" valign="top" rowspan="1" colspan="1">59</td><td align="center" valign="top" rowspan="1" colspan="1">32%</td></tr><tr><td align="left" valign="top" rowspan="6" colspan="1">3</td><td align="left" valign="top" rowspan="6" colspan="1">Education</td><td align="left" valign="top" rowspan="1" colspan="1">Primary</td><td align="center" valign="top" rowspan="1" colspan="1">107</td><td align="center" valign="top" rowspan="1" colspan="1">1.02%</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">1.26%</td><td align="center" valign="top" rowspan="6" colspan="1">3</td><td align="left" valign="top" rowspan="6" colspan="1">Education</td><td align="left" valign="top" rowspan="1" colspan="1">Primary</td><td align="center" valign="top" rowspan="1" colspan="1">519</td><td align="center" valign="top" rowspan="1" colspan="1">29%</td><td align="center" valign="top" rowspan="1" colspan="1">55</td><td align="center" valign="top" rowspan="1" colspan="1">30%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Matric</td><td align="center" valign="top" rowspan="1" colspan="1">106</td><td align="center" valign="top" rowspan="1" colspan="1">1.01%</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">0.84%</td><td align="left" valign="top" rowspan="1" colspan="1">Matric</td><td align="center" valign="top" rowspan="1" colspan="1">342</td><td align="center" valign="top" rowspan="1" colspan="1">19%</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">9%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Intermediate</td><td align="center" valign="top" rowspan="1" colspan="1">1,251</td><td align="center" valign="top" rowspan="1" colspan="1">11.95%</td><td align="center" valign="top" rowspan="1" colspan="1">36</td><td align="center" valign="top" rowspan="1" colspan="1">7.53%</td><td align="left" valign="top" rowspan="1" colspan="1">Intermediate</td><td align="center" valign="top" rowspan="1" colspan="1">202</td><td align="center" valign="top" rowspan="1" colspan="1">11%</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">3%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Graduate</td><td align="center" valign="top" rowspan="1" colspan="1">6,845</td><td align="center" valign="top" rowspan="1" colspan="1">65.38%</td><td align="center" valign="top" rowspan="1" colspan="1">215</td><td align="center" valign="top" rowspan="1" colspan="1">44.98%</td><td align="left" valign="top" rowspan="1" colspan="1">Graduate</td><td align="center" valign="top" rowspan="1" colspan="1">245</td><td align="center" valign="top" rowspan="1" colspan="1">14%</td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">6%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Post Graduate</td><td align="center" valign="top" rowspan="1" colspan="1">1,585</td><td align="center" valign="top" rowspan="1" colspan="1">15.14%</td><td align="center" valign="top" rowspan="1" colspan="1">55</td><td align="center" valign="top" rowspan="1" colspan="1">11.51%</td><td align="left" valign="top" rowspan="1" colspan="1">Post Graduate</td><td align="center" valign="top" rowspan="1" colspan="1">99</td><td align="center" valign="top" rowspan="1" colspan="1">6%</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">3%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Not Answered</td><td align="center" valign="top" rowspan="1" colspan="1">576</td><td align="center" valign="top" rowspan="1" colspan="1">5.50%</td><td align="center" valign="top" rowspan="1" colspan="1">162</td><td align="center" valign="top" rowspan="1" colspan="1">33.89%</td><td align="left" valign="top" rowspan="1" colspan="1">Not Answered</td><td align="center" valign="top" rowspan="1" colspan="1">376</td><td align="center" valign="top" rowspan="1" colspan="1">21%</td><td align="center" valign="top" rowspan="1" colspan="1">91</td><td align="center" valign="top" rowspan="1" colspan="1">49%</td></tr><tr><td align="left" valign="top" rowspan="5" colspan="1">4</td><td align="left" valign="top" rowspan="5" colspan="1">Income</td><td align="left" valign="top" rowspan="1" colspan="1">10,000&#8211;20,000</td><td align="center" valign="top" rowspan="1" colspan="1">1,148</td><td align="center" valign="top" rowspan="1" colspan="1">10.96%</td><td align="center" valign="top" rowspan="1" colspan="1">54</td><td align="center" valign="top" rowspan="1" colspan="1">11.30%</td><td align="center" valign="top" rowspan="5" colspan="1">4</td><td align="left" valign="top" rowspan="5" colspan="1">Income</td><td align="left" valign="top" rowspan="1" colspan="1">10,000&#8211;20,000</td><td align="center" valign="top" rowspan="1" colspan="1">566</td><td align="center" valign="top" rowspan="1" colspan="1">32%</td><td align="center" valign="top" rowspan="1" colspan="1">49</td><td align="center" valign="top" rowspan="1" colspan="1">26%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Above 20,000</td><td align="center" valign="top" rowspan="1" colspan="1">1,169</td><td align="center" valign="top" rowspan="1" colspan="1">11.17%</td><td align="center" valign="top" rowspan="1" colspan="1">41</td><td align="center" valign="top" rowspan="1" colspan="1">8.58%</td><td align="left" valign="top" rowspan="1" colspan="1">Above 20,000</td><td align="center" valign="top" rowspan="1" colspan="1">402</td><td align="center" valign="top" rowspan="1" colspan="1">23%</td><td align="center" valign="top" rowspan="1" colspan="1">38</td><td align="center" valign="top" rowspan="1" colspan="1">21%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Below 50,000</td><td align="center" valign="top" rowspan="1" colspan="1">4,782</td><td align="center" valign="top" rowspan="1" colspan="1">45.67%</td><td align="center" valign="top" rowspan="1" colspan="1">156</td><td align="center" valign="top" rowspan="1" colspan="1">32.64%</td><td align="left" valign="top" rowspan="1" colspan="1">Below 50,000</td><td align="center" valign="top" rowspan="1" colspan="1">497</td><td align="center" valign="top" rowspan="1" colspan="1">28%</td><td align="center" valign="top" rowspan="1" colspan="1">30</td><td align="center" valign="top" rowspan="1" colspan="1">16%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Above 50,000</td><td align="center" valign="top" rowspan="1" colspan="1">2,806</td><td align="center" valign="top" rowspan="1" colspan="1">26.80%</td><td align="center" valign="top" rowspan="1" colspan="1">61</td><td align="center" valign="top" rowspan="1" colspan="1">12.76%</td><td align="left" valign="top" rowspan="1" colspan="1">Above 50,000</td><td align="center" valign="top" rowspan="1" colspan="1">200</td><td align="center" valign="top" rowspan="1" colspan="1">11%</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">4%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Not Answered</td><td align="center" valign="top" rowspan="1" colspan="1">565</td><td align="center" valign="top" rowspan="1" colspan="1">5.40%</td><td align="center" valign="top" rowspan="1" colspan="1">166</td><td align="center" valign="top" rowspan="1" colspan="1">34.73%</td><td align="left" valign="top" rowspan="1" colspan="1">Not Answered</td><td align="center" valign="top" rowspan="1" colspan="1">118</td><td align="center" valign="top" rowspan="1" colspan="1">7%</td><td align="center" valign="top" rowspan="1" colspan="1">59</td><td align="center" valign="top" rowspan="1" colspan="1">32%</td></tr><tr><td align="left" valign="top" rowspan="3" colspan="1">5</td><td align="left" valign="top" rowspan="3" colspan="1">Marital status</td><td align="left" valign="top" rowspan="1" colspan="1">Single</td><td align="center" valign="top" rowspan="1" colspan="1">9,571</td><td align="center" valign="top" rowspan="1" colspan="1">91.41%</td><td align="center" valign="top" rowspan="1" colspan="1">290</td><td align="center" valign="top" rowspan="1" colspan="1">60.67%</td><td align="center" valign="top" rowspan="3" colspan="1">5</td><td align="left" valign="top" rowspan="3" colspan="1">Marital status</td><td align="left" valign="top" rowspan="1" colspan="1">Single</td><td align="center" valign="top" rowspan="1" colspan="1">629</td><td align="center" valign="top" rowspan="1" colspan="1">35%</td><td align="center" valign="top" rowspan="1" colspan="1">26</td><td align="center" valign="top" rowspan="1" colspan="1">14%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Married</td><td align="center" valign="top" rowspan="1" colspan="1">899</td><td align="center" valign="top" rowspan="1" colspan="1">8.59%</td><td align="center" valign="top" rowspan="1" colspan="1">48</td><td align="center" valign="top" rowspan="1" colspan="1">10.04%</td><td align="left" valign="top" rowspan="1" colspan="1">Married</td><td align="center" valign="top" rowspan="1" colspan="1">1,154</td><td align="center" valign="top" rowspan="1" colspan="1">65%</td><td align="center" valign="top" rowspan="1" colspan="1">109</td><td align="center" valign="top" rowspan="1" colspan="1">59%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Not Answered</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0.00%</td><td align="center" valign="top" rowspan="1" colspan="1">140</td><td align="center" valign="top" rowspan="1" colspan="1">29.29%</td><td align="left" valign="top" rowspan="1" colspan="1">Not Answered</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0%</td><td align="center" valign="top" rowspan="1" colspan="1">49</td><td align="center" valign="top" rowspan="1" colspan="1">26%</td></tr><tr><td align="left" valign="top" rowspan="3" colspan="1">6</td><td align="left" valign="top" rowspan="3" colspan="1">Household contacts</td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="center" valign="top" rowspan="1" colspan="1">824</td><td align="center" valign="top" rowspan="1" colspan="1">8%</td><td align="center" valign="top" rowspan="1" colspan="1">79</td><td align="center" valign="top" rowspan="1" colspan="1">17%</td><td align="center" valign="top" rowspan="3" colspan="1">6</td><td align="left" valign="top" rowspan="3" colspan="1">Household contacts</td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="center" valign="top" rowspan="1" colspan="1">78</td><td align="center" valign="top" rowspan="1" colspan="1">4%</td><td align="center" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">7%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">No</td><td align="center" valign="top" rowspan="1" colspan="1">9,646</td><td align="center" valign="top" rowspan="1" colspan="1">92%</td><td align="center" valign="top" rowspan="1" colspan="1">399</td><td align="center" valign="top" rowspan="1" colspan="1">83%</td><td align="left" valign="top" rowspan="1" colspan="1">No</td><td align="center" valign="top" rowspan="1" colspan="1">1705</td><td align="center" valign="top" rowspan="1" colspan="1">96%</td><td align="center" valign="top" rowspan="1" colspan="1">171</td><td align="center" valign="top" rowspan="1" colspan="1">92%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Not Answered</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0%</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0%</td><td align="left" valign="top" rowspan="1" colspan="1">Not Answered</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0%</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0%</td></tr><tr><td align="left" valign="top" rowspan="3" colspan="1">7</td><td align="left" valign="top" rowspan="3" colspan="1">Infection history in relative</td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="center" valign="top" rowspan="1" colspan="1">61</td><td align="center" valign="top" rowspan="1" colspan="1">1%</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">2%</td><td align="center" valign="top" rowspan="3" colspan="1">7</td><td align="left" valign="top" rowspan="3" colspan="1">Infection history in relative</td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">1%</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">1%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">No</td><td align="center" valign="top" rowspan="1" colspan="1">10,409</td><td align="center" valign="top" rowspan="1" colspan="1">99%</td><td align="center" valign="top" rowspan="1" colspan="1">470</td><td align="center" valign="top" rowspan="1" colspan="1">98%</td><td align="left" valign="top" rowspan="1" colspan="1">No</td><td align="center" valign="top" rowspan="1" colspan="1">5,176</td><td align="center" valign="top" rowspan="1" colspan="1">290%</td><td align="center" valign="top" rowspan="1" colspan="1">182</td><td align="center" valign="top" rowspan="1" colspan="1">98%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Not Answered</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0%</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0%</td><td align="left" valign="top" rowspan="1" colspan="1">Not Answered</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0%</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0%</td></tr><tr><td align="left" valign="top" rowspan="3" colspan="1">8</td><td align="left" valign="top" rowspan="3" colspan="1">Marriage trend</td><td align="left" valign="top" rowspan="1" colspan="1">Interfamily</td><td align="center" valign="top" rowspan="1" colspan="1">4,455</td><td align="center" valign="top" rowspan="1" colspan="1">43%</td><td align="center" valign="top" rowspan="1" colspan="1">139</td><td align="center" valign="top" rowspan="1" colspan="1">29%</td><td align="center" valign="top" rowspan="3" colspan="1">8</td><td align="left" valign="top" rowspan="3" colspan="1">Marriage trend</td><td align="left" valign="top" rowspan="1" colspan="1">Interfamily</td><td align="center" valign="top" rowspan="1" colspan="1">598</td><td align="center" valign="top" rowspan="1" colspan="1">34%</td><td align="center" valign="top" rowspan="1" colspan="1">46</td><td align="center" valign="top" rowspan="1" colspan="1">25%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Intrafamily</td><td align="center" valign="top" rowspan="1" colspan="1">5,558</td><td align="center" valign="top" rowspan="1" colspan="1">53%</td><td align="center" valign="top" rowspan="1" colspan="1">325</td><td align="center" valign="top" rowspan="1" colspan="1">68%</td><td align="left" valign="top" rowspan="1" colspan="1">Intrafamily</td><td align="center" valign="top" rowspan="1" colspan="1">1,032</td><td align="center" valign="top" rowspan="1" colspan="1">58%</td><td align="center" valign="top" rowspan="1" colspan="1">131</td><td align="center" valign="top" rowspan="1" colspan="1">71%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Not Answered</td><td align="center" valign="top" rowspan="1" colspan="1">457</td><td align="center" valign="top" rowspan="1" colspan="1">4%</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">3%</td><td align="left" valign="top" rowspan="1" colspan="1">Not Answered</td><td align="center" valign="top" rowspan="1" colspan="1">153</td><td align="center" valign="top" rowspan="1" colspan="1">9%</td><td align="center" valign="top" rowspan="1" colspan="1">7</td><td align="center" valign="top" rowspan="1" colspan="1">4%</td></tr><tr><td align="left" valign="top" rowspan="2" colspan="1">9</td><td align="left" valign="top" rowspan="2" colspan="1">Mother-infected with hepatitis</td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="center" valign="top" rowspan="1" colspan="1">284</td><td align="center" valign="top" rowspan="1" colspan="1">2.71%</td><td align="center" valign="top" rowspan="1" colspan="1">23</td><td align="center" valign="top" rowspan="1" colspan="1">4.8%</td><td align="center" valign="top" rowspan="2" colspan="1">9</td><td align="left" valign="top" rowspan="2" colspan="1">Mother-infected with hepatitis</td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">1.06%</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">1.08%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">No</td><td align="center" valign="top" rowspan="1" colspan="1">10,186</td><td align="center" valign="top" rowspan="1" colspan="1">97.2%</td><td align="center" valign="top" rowspan="1" colspan="1">455</td><td align="center" valign="top" rowspan="1" colspan="1">95.1%</td><td align="left" valign="top" rowspan="1" colspan="1">No</td><td align="center" valign="top" rowspan="1" colspan="1">1761</td><td align="center" valign="top" rowspan="1" colspan="1">98.9%</td><td align="center" valign="top" rowspan="1" colspan="1">182</td><td align="center" valign="top" rowspan="1" colspan="1">98.9%</td></tr></tbody></table></table-wrap></sec><sec id="sec24"><label>3.3</label><title>Distribution of hepatitis strains among participants</title><p>The 95% (630/662) detected (via immunochromatographic test (ICT) strip) hepatitis cases were tested further for PCR confirmation. Among them, 83.9% (529/630) were found to be true positive, i.e., positive results both by ICT strip and PCR and 16.03% (101/630) were noted to be false positive, i.e., positive results by ICT strip test while negative by PCR. For 1.2% (8/662), resampling was done, while 3.63% (24/662) samples of hepatitis-positive participants were not available (<xref rid="fig2" ref-type="fig">Figure 2</xref>). Viral count detection revealed a high viral load (<xref rid="fig3" ref-type="fig">Figure 3</xref>) in the majority of HCV-positive participants (57%) and a low HBV viral count in the majority of HBV positive participants (71%). The HCV was observed to be the most prevalent strain among hepatitis-positive participants with a frequency of 57.23% in male students, 63.64% in female students, 71.90% in male employees, and 84.13% in female employees. Among hepatitis positive individuals, a total of 41.91% of male students, 36.36% of female students, 27.27% of male employees, and 15.87% of female employee were confirmed to have HBV infection. There were only a few (0.87%) male students and 0.83% female students who tested positive for co-infection of HBV and HCV (<xref rid="fig4" ref-type="fig">Figure 4</xref>).</p><fig position="float" id="fig2" orientation="portrait"><label>Figure 2</label><caption><p>Hepatitis confirmation results by PCR. Represents the total samples for which PCR confirmation was done, the true positive and false positive percentage detected by PCR, re-sampling, and missing samples frequencies.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fpubh-11-1269209-g002.jpg"/></fig><fig position="float" id="fig3" orientation="portrait"><label>Figure 3</label><caption><p>Hepatitis viral count. <bold>(A)</bold> HCV viral load frequency detected in hepatitis-positive participants. <bold>(B)</bold> HBV viral load frequency detected in hepatitis-positive participants. Viral count of &gt;8,00,000&#8201;IU/mL recorded as high a viral load, &lt;8,00,000&#8201;IU/mL to be a low viral load, and&#8201;&lt;&#8201;20&#8201;IU/mL equals a very low viral load detected among hepatitis-positive participants. HBV, Hepatitis B virus; HCV, Hepatitis C virus.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fpubh-11-1269209-g003.jpg"/></fig><fig position="float" id="fig4" orientation="portrait"><label>Figure 4</label><caption><p>Distribution of hepatitis strains among hepatitis-positive participants. The prevalence of HBC, HBV, and co-infection of HBC and HBV was represented. HBV, Hepatitis B virus; HCV, Hepatitis C virus.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fpubh-11-1269209-g004.jpg"/></fig></sec><sec id="sec25"><label>3.4</label><title>Prevalence and association of medical-related hepatitis risk factors</title><p>Evaluation of different risk factor frequencies and Pearson correlation measurements represent contrasting results. The frequency of some factors was found to be highest amongst hepatitis-negative participants. Frequencies of different blood groups varied among participants, but in hepatitis-positive and negative student participants, the B+ blood group was observed to be more prevalent (hepatitis positive students&#8201;=&#8201;20%, hepatitis negative students&#8201;=&#8201;24%, hepatitis-positive employee&#8201;=&#8201;15%, and hepatitis-negative employee&#8201;=&#8201;17%). The blood group was found to be not associated i.e., <italic toggle="yes">p</italic>-value 0.97 (students), <italic toggle="yes">p</italic>-value 0.08 (employees) with hepatitis. Another factor blood transfusion frequency was found to be 14% in hepatitis-negative students and 12% in hepatitis-positive students; 17% was detected in both the hepatitis-positive and negative employee participants. The <italic toggle="yes">X<sup>2</sup></italic> shows no association of blood transfusion (<italic toggle="yes">p</italic>-value 0.79 in students, <italic toggle="yes">p</italic>-value 0.89 in employees) with hepatitis. Dental treatment frequency was found to be higher in the hepatitis-negative participants, with students at 15% and employees at 13%, while in the hepatitis-positive participants 12% was noted in students and 18% was noted in employees. The <italic toggle="yes">X<sup>2</sup></italic> test reveals the relation of it with hepatitis as Pearson correlation value (3.694, <italic toggle="yes">p</italic>-value 0.05) was noted in the student group. More frequent facial treatments was observed among hepatitis-positive students (12%) than among hepatitis-negative students (6%). A very small number (1% hepatitis positive and 2% hepatitis negative) of participants (employees) were found to have facial treatment records and were found to be not linked (<italic toggle="yes">p</italic>-value 0.1 and <italic toggle="yes">p</italic>-value 0.23) with hepatitis. A total of 9% of hepatitis positive and 7% of hepatitis-negative participants (students) reported surgical history. Of employees, 17% of hepatitis-positive participants and 12% of hepatitis-negative participants reported having surgery in their life. An association of surgery (<italic toggle="yes">X<sup>2</sup></italic>&#8201;=&#8201;4.21, <italic toggle="yes">p</italic>-value 0.04) with hepatitis was shown by the employee group only. Neither the students nor employees were found to have a drug addiction and were not found to be associated (<italic toggle="yes">p</italic>-value 0.45 and <italic toggle="yes">p</italic>-value 0.78) with hepatitis in any group, respectively. We have observed that 15% of already vaccinated student participants and 12% of employee participants to be hepatitis positive while amongst hepatitis-negative participants only 8% of students and 5% of employees were observed to be already vaccinated. The association was found by the <italic toggle="yes">X<sup>2</sup></italic> test with a measure of 21.09, <italic toggle="yes">p</italic>-value 0.00 in students and 13.2, and <italic toggle="yes">p</italic>-value 0.00 in the employees group (<xref rid="fig5" ref-type="fig">Figures 5</xref>, <xref rid="fig6" ref-type="fig">6</xref>, <xref rid="tab2" ref-type="table">Table 2</xref>, and <xref rid="SM1" ref-type="supplementary-material">Supplementary Tables S1, S2</xref>).</p><fig position="float" id="fig5" orientation="portrait"><label>Figure 5</label><caption><p>Frequency of various risk factors in hepatitis negative and positive students. <bold>(A)</bold> Frequencies of medical-associated factors. <bold>(B)</bold> Frequencies of behavioral-related factors.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fpubh-11-1269209-g005.jpg"/></fig><fig position="float" id="fig6" orientation="portrait"><label>Figure 6</label><caption><p>Frequency of various risk factors in hepatitis negative and positive employees. <bold>(A)</bold> Frequencies of medical-associated factors. <bold>(B)</bold> Frequencies of behavioral-related factors.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fpubh-11-1269209-g006.jpg"/></fig><table-wrap position="float" id="tab2" orientation="portrait"><label>Table 2</label><caption><p>Association of medical and behavioral risk factors with hepatitis.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Sr. No.</th><th align="left" valign="top" rowspan="1" colspan="1">Risk factors</th><th align="left" valign="top" rowspan="2" colspan="1">Groups</th><th align="center" valign="top" rowspan="2" colspan="1"><italic toggle="yes">X</italic><sup>2</sup> values</th><th align="center" valign="top" rowspan="2" colspan="1"><italic toggle="yes">p</italic>-value</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1">A.</th><th align="left" valign="top" rowspan="1" colspan="1">Medical related risk factors</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="2" colspan="1">1</td><td align="left" valign="top" rowspan="2" colspan="1">Blood group</td><td align="left" valign="top" rowspan="1" colspan="1">Patients students</td><td align="center" valign="top" rowspan="1" colspan="1">1.79</td><td align="center" valign="top" rowspan="1" colspan="1">0.971</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patients employees</td><td align="center" valign="top" rowspan="1" colspan="1">12.56</td><td align="center" valign="top" rowspan="1" colspan="1">0.083</td></tr><tr><td align="left" valign="top" rowspan="2" colspan="1">2</td><td align="left" valign="top" rowspan="2" colspan="1">Blood transfusion</td><td align="left" valign="top" rowspan="1" colspan="1">Patients students</td><td align="center" valign="top" rowspan="1" colspan="1">0.66</td><td align="center" valign="top" rowspan="1" colspan="1">0.797</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patients employees</td><td align="center" valign="top" rowspan="1" colspan="1">0.17</td><td align="center" valign="top" rowspan="1" colspan="1">0.897</td></tr><tr><td align="left" valign="top" rowspan="2" colspan="1">3</td><td align="left" valign="top" rowspan="2" colspan="1">Dental treatment</td><td align="left" valign="top" rowspan="1" colspan="1">Patients students</td><td align="center" valign="top" rowspan="1" colspan="1">3.694</td><td align="center" valign="top" rowspan="1" colspan="1">0.05</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patients employees</td><td align="center" valign="top" rowspan="1" colspan="1">2.26</td><td align="center" valign="top" rowspan="1" colspan="1">0.132</td></tr><tr><td align="left" valign="top" rowspan="2" colspan="1">4</td><td align="left" valign="top" rowspan="2" colspan="1">Facial treatment</td><td align="left" valign="top" rowspan="1" colspan="1">Patients students</td><td align="center" valign="top" rowspan="1" colspan="1">6.653</td><td align="center" valign="top" rowspan="1" colspan="1">0.1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patients employees</td><td align="center" valign="top" rowspan="1" colspan="1">1.39</td><td align="center" valign="top" rowspan="1" colspan="1">0.238</td></tr><tr><td align="left" valign="top" rowspan="2" colspan="1">5</td><td align="left" valign="top" rowspan="2" colspan="1">Surgery</td><td align="left" valign="top" rowspan="1" colspan="1">Patients students</td><td align="center" valign="top" rowspan="1" colspan="1">1.36</td><td align="center" valign="top" rowspan="1" colspan="1">0.243</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patients employees</td><td align="center" valign="top" rowspan="1" colspan="1">4.21</td><td align="center" valign="top" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" valign="top" rowspan="2" colspan="1">6</td><td align="left" valign="top" rowspan="2" colspan="1">Drug addiction</td><td align="left" valign="top" rowspan="1" colspan="1">Patients students</td><td align="center" valign="top" rowspan="1" colspan="1">0.25</td><td align="center" valign="top" rowspan="1" colspan="1">0.611 (Fisher value 0.465)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patients employees</td><td align="center" valign="top" rowspan="1" colspan="1">0.103</td><td align="center" valign="top" rowspan="1" colspan="1">0.748</td></tr><tr><td align="left" valign="top" rowspan="3" colspan="1">7</td><td align="left" valign="top" rowspan="3" colspan="1">Already vaccinated against hepatitis</td><td align="left" valign="top" rowspan="1" colspan="1">Patients students</td><td align="center" valign="top" rowspan="1" colspan="1">21.09</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patients employees</td><td align="center" valign="top" rowspan="1" colspan="1">13.2</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patients employees</td><td align="center" valign="top" rowspan="1" colspan="1">116.9</td><td align="center" valign="top" rowspan="1" colspan="1">0.00</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">B.</td><td align="left" valign="top" colspan="4" rowspan="1">Behavioral related risk factors</td></tr><tr><td align="left" valign="top" rowspan="2" colspan="1">1</td><td align="left" valign="top" rowspan="2" colspan="1">Smoking</td><td align="left" valign="top" rowspan="1" colspan="1">Patients students</td><td align="center" valign="top" rowspan="1" colspan="1">0.345</td><td align="center" valign="top" rowspan="1" colspan="1">0.559</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patients employees</td><td align="center" valign="top" rowspan="1" colspan="1">0.274</td><td align="center" valign="top" rowspan="1" colspan="1">0.6</td></tr><tr><td align="left" valign="top" rowspan="2" colspan="1">2</td><td align="left" valign="top" rowspan="2" colspan="1">Avoid reused syringes</td><td align="left" valign="top" rowspan="1" colspan="1">Patients students</td><td align="center" valign="top" rowspan="1" colspan="1">45.16</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patients employees</td><td align="center" valign="top" rowspan="1" colspan="1">21.05</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="2" colspan="1">3</td><td align="left" valign="top" rowspan="2" colspan="1">Sharing of towel</td><td align="left" valign="top" rowspan="1" colspan="1">Patients students</td><td align="center" valign="top" rowspan="1" colspan="1">1.9</td><td align="center" valign="top" rowspan="1" colspan="1">0.168</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patients employees</td><td align="center" valign="top" rowspan="1" colspan="1">0.319</td><td align="center" valign="top" rowspan="1" colspan="1">0.572</td></tr><tr><td align="left" valign="top" rowspan="2" colspan="1">4</td><td align="left" valign="top" rowspan="2" colspan="1">Sharing of shaving razors/machine</td><td align="left" valign="top" rowspan="1" colspan="1">Patients students</td><td align="center" valign="top" rowspan="1" colspan="1">19.9</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patients employees</td><td align="center" valign="top" rowspan="1" colspan="1">1.39</td><td align="center" valign="top" rowspan="1" colspan="1">0.238</td></tr><tr><td align="left" valign="top" rowspan="2" colspan="1">5</td><td align="left" valign="top" rowspan="2" colspan="1">Sharing of cosmetics</td><td align="left" valign="top" rowspan="1" colspan="1">Patients students</td><td align="center" valign="top" rowspan="1" colspan="1">32.55</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patients employees</td><td align="center" valign="top" rowspan="1" colspan="1">0.19</td><td align="center" valign="top" rowspan="1" colspan="1">0.892</td></tr></tbody></table><table-wrap-foot><p>Fisher&#8217;s exact value was given for the variables not meeting the chi-square assumption of &#8220;expected count not less than 5 in each cell.&#8221; Alpha criterion&#8201;=&#8201;0.05.</p></table-wrap-foot></table-wrap></sec><sec id="sec26"><label>3.5</label><title>Prevalence and association of behavioral-related hepatitis risk factors</title><p>Assessment of behavioral-related factors shows that, amongst hepatitis- positive participants, smoking was reported in 8% of students and 10% of employees, while among hepatitis-negative participants smoking was observed in 7% of students and 9% of employees and was not found to have a relation with hepatitis (<italic toggle="yes">p</italic>-value&#8201;&gt;&#8201;0.5). Analysis of reusing the used syringes displays that 77% of hepatitis positive students, 79% of hepatitis negative students, 73% of hepatitis positive employees, and 69% of hepatitis negative employees made sure to use new syringes. The <italic toggle="yes">X<sup>2</sup></italic> calculation shows it to be associated with students (48.3%, <italic toggle="yes">p</italic>-value 0.00). Among hepatitis-positive participants, a total of 56% (students) and 46% (employees) share their towels while among hepatitis-negative participants 57% of students and 47% of employees do the same, but this shows no significant association in either group [0.9, <italic toggle="yes">p</italic>-value 0.16 (students) and 0.3 <italic toggle="yes">p</italic>-value 0.57 (employees)].</p><p>Of the participants, 64% of hepatitis positive students, 56% of hepatitis negative students, 54% of hepatitis positive employees, and 50% of hepatitis negative employees share shaving razors/machines and this was found to be significant (19.9, <italic toggle="yes">p</italic>-value 0.00) in the student group.</p><p>Whereas, amongst females, 17% of hepatitis-positive students, 32% of hepatitis-negative students, 15% of hepatitis-positive employees, and 16% of hepatitis-negative students were reported to share their cosmetics. The <italic toggle="yes">X<sup>2</sup></italic> test&#8217;s value was shown to be 32.5 (<italic toggle="yes">p</italic>-value 0.00) in the students group (<xref rid="tab2" ref-type="table">Table 2</xref>, <xref rid="fig5" ref-type="fig">Figures 5</xref>, <xref rid="fig6" ref-type="fig">6</xref>, and <xref rid="SM1" ref-type="supplementary-material">Supplementary Tables S1, S2</xref>).</p></sec><sec id="sec27"><label>3.6</label><title>Independent variables association with hepatitis by binary logistic regression</title><p>To explore the extent of risk factors&#8217; influence on hepatitis, variables were analyzed individually by logistic regression. Multicollinearity assumptions were tested and found to be satisfied for binary logistic regression by all variables, i.e., tolerance value was greater than 0.1 and variance inflation factor (VIF) value was less than 5 and, hence, non-collinearity was detected among variables (<xref rid="SM1" ref-type="supplementary-material">Supplementary Tables S4, S5</xref>). All variables in the equation were shown in <xref rid="SM1" ref-type="supplementary-material">Supplementary Tables S6, S7</xref>.</p><p>Logistic regression analysis depicted different predictor variables to be linked with each group. In students, gender (male) with an adjusted odd ratio (AOR&#8201;=&#8201;2.102 [95% CI&#8201;=&#8201;1.62&#8211;2.71]), sharing shaving razors (AOR&#8201;=&#8201;1.41, [95% CI&#8201;=&#8201;1.14&#8211;1.76]), and vaccination (AOR&#8201;=&#8201;1.87, [95% CI&#8201;=&#8201;1.44&#8211;2.44]) was positively associated with hepatitis. However, income above 50,000 (AOR&#8201;=&#8201;0.506, [95% CI&#8201;=&#8201;0.334&#8211;0.745]), below 50,000 (AOR&#8201;=&#8201;0.71,[95% CI&#8201;=&#8201;0.511&#8211;0.987]), marital status (AOR&#8201;=&#8201;0.451, [95% CI&#8201;=&#8201;0.278&#8211;0.732]), dental treatment (AOR&#8201;=&#8201;0.744, [95% CI&#8201;=&#8201;0.558&#8211;0.991]), facial treatment (AOR&#8201;=&#8201;0.532, [95% CI&#8201;=&#8201;0.320&#8211;0.883]), and cosmetics sharing (AOR&#8201;=&#8201;0.547, [95% CI&#8201;=&#8201;0.425&#8211;0.703]) were found to be negatively linked with the likelihood of hepatitis in students (<xref rid="tab3" ref-type="table">Table 3</xref>).</p><table-wrap position="float" id="tab3" orientation="portrait"><label>Table 3</label><caption><p>Independent risk factors significantly associated with hepatitis (students group).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="2" colspan="1">Risk factors</th><th align="center" valign="top" rowspan="2" colspan="1">B</th><th align="center" valign="top" rowspan="2" colspan="1">S.E.</th><th align="center" valign="top" rowspan="2" colspan="1">Wald</th><th align="center" valign="top" rowspan="2" colspan="1">df<sup>a</sup></th><th align="center" valign="top" rowspan="2" colspan="1">Sig.</th><th align="center" valign="top" rowspan="2" colspan="1">EXP(B) (AOR<sup>b</sup>)</th><th align="center" valign="top" colspan="2" rowspan="1">95% C.I. for EXP(B)</th></tr><tr><th align="center" valign="top" rowspan="1" colspan="1">Lower</th><th align="center" valign="top" rowspan="1" colspan="1">Upper</th></tr></thead><tbody><tr><td align="left" valign="top" colspan="9" rowspan="1">Socio-economic related factors</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Gender (Male)</td><td align="center" valign="top" rowspan="1" colspan="1">0.743</td><td align="center" valign="top" rowspan="1" colspan="1">0.131</td><td align="center" valign="top" rowspan="1" colspan="1">32.094</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.00</td><td align="center" valign="top" rowspan="1" colspan="1">2.102</td><td align="center" valign="top" rowspan="1" colspan="1">1.625</td><td align="center" valign="top" rowspan="1" colspan="1">2.718</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Income</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">12.085</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">0.007</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Above 50,000</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;0.681</td><td align="center" valign="top" rowspan="1" colspan="1">0.197</td><td align="center" valign="top" rowspan="1" colspan="1">11.956</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.506</td><td align="center" valign="top" rowspan="1" colspan="1">0.344</td><td align="center" valign="top" rowspan="1" colspan="1">0.745</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Below 50,000</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;0.342</td><td align="center" valign="top" rowspan="1" colspan="1">0.168</td><td align="center" valign="top" rowspan="1" colspan="1">4.156</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.04</td><td align="center" valign="top" rowspan="1" colspan="1">0.710</td><td align="center" valign="top" rowspan="1" colspan="1">0.511</td><td align="center" valign="top" rowspan="1" colspan="1">0.987</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Marital status</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;0.796</td><td align="center" valign="top" rowspan="1" colspan="1">0.247</td><td align="center" valign="top" rowspan="1" colspan="1">10.390</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.451</td><td align="center" valign="top" rowspan="1" colspan="1">0.278</td><td align="center" valign="top" rowspan="1" colspan="1">0.732</td></tr><tr><td align="left" valign="top" colspan="9" rowspan="1">Medical related factors</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Dental treatment</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;0.296</td><td align="center" valign="top" rowspan="1" colspan="1">0.147</td><td align="center" valign="top" rowspan="1" colspan="1">4.075</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.044</td><td align="center" valign="top" rowspan="1" colspan="1">0.744</td><td align="center" valign="top" rowspan="1" colspan="1">0.558</td><td align="center" valign="top" rowspan="1" colspan="1">0.991</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Facial treatment</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;0.631</td><td align="center" valign="top" rowspan="1" colspan="1">0.259</td><td align="center" valign="top" rowspan="1" colspan="1">5.948</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.015</td><td align="center" valign="top" rowspan="1" colspan="1">0.532</td><td align="center" valign="top" rowspan="1" colspan="1">0.320</td><td align="center" valign="top" rowspan="1" colspan="1">0.883</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Already vaccinated</td><td align="center" valign="top" rowspan="1" colspan="1">0.630</td><td align="center" valign="top" rowspan="1" colspan="1">0.134</td><td align="center" valign="top" rowspan="1" colspan="1">21.991</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.000</td><td align="center" valign="top" rowspan="1" colspan="1">1.877</td><td align="center" valign="top" rowspan="1" colspan="1">1.443</td><td align="center" valign="top" rowspan="1" colspan="1">2.442</td></tr><tr><td align="left" valign="top" colspan="9" rowspan="1">Behavioral related risk factors</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sharing shave razors/machines</td><td align="center" valign="top" rowspan="1" colspan="1">0.350</td><td align="center" valign="top" rowspan="1" colspan="1">0.110</td><td align="center" valign="top" rowspan="1" colspan="1">10.148</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.419</td><td align="center" valign="top" rowspan="1" colspan="1">1.144</td><td align="center" valign="top" rowspan="1" colspan="1">1.761</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sharing cosmetics</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;0.604</td><td align="center" valign="top" rowspan="1" colspan="1">0.129</td><td align="center" valign="top" rowspan="1" colspan="1">22.029</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.000</td><td align="center" valign="top" rowspan="1" colspan="1">0.547</td><td align="center" valign="top" rowspan="1" colspan="1">0.425</td><td align="center" valign="top" rowspan="1" colspan="1">0.703</td></tr></tbody></table><table-wrap-foot><p>Reference category was chosen to be 1st. Sig., Significant values (<italic toggle="yes">p</italic>-values&#8201;&lt;&#8201;0.05); <sup>a</sup> df, Degree of freedom; <sup>b</sup> AOR, Adjusted odd ratio.</p></table-wrap-foot></table-wrap><p>In employees, age group of 25&#8211;40&#8201;years (AOR&#8201;=&#8201;4.406, [95% CI&#8201;=&#8201;2.094&#8211;9.286]), 41&#8211;50&#8201;years (AOR&#8201;=&#8201;4.721, [95% CI&#8201;=&#8201;2.118&#8211;10.523]), above 50&#8201;years (AOR&#8201;=&#8201;3.393, [95% CI&#8201;=&#8201;1.407&#8211;8.185]), primary education (AOR&#8201;=&#8201;2.313, [95% CI&#8201;=&#8201;1.114&#8211;4.803]), household contacts (AOR&#8201;=&#8201;2.013, [95% CI&#8201;=&#8201;1.054&#8211;3.844]), surgery (AOR&#8201;=&#8201;1.653, [95% CI&#8201;=&#8201;1.086&#8211;2.514]), and vaccination (AOR&#8201;=&#8201;2.331, [95% CI&#8201;=&#8201;1.408&#8211;3.859]) were associated with a positive likelihood of hepatitis (<xref rid="tab4" ref-type="table">Table 4</xref>).</p><table-wrap position="float" id="tab4" orientation="portrait"><label>Table 4</label><caption><p>Independent risk factors significantly associated with hepatitis (employees group).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="2" colspan="1">Risk factors</th><th align="center" valign="top" rowspan="2" colspan="1">B</th><th align="center" valign="top" rowspan="2" colspan="1">S.E.</th><th align="center" valign="top" rowspan="2" colspan="1">Wald</th><th align="center" valign="top" rowspan="2" colspan="1">df<sup>a</sup></th><th align="center" valign="top" rowspan="2" colspan="1">Sig.</th><th align="center" valign="top" rowspan="2" colspan="1">EXP(B) (AOR<sup>b</sup>)</th><th align="center" valign="top" colspan="2" rowspan="1">95% C.I. for EXP(B)</th></tr><tr><th align="center" valign="top" rowspan="1" colspan="1">Lower</th><th align="center" valign="top" rowspan="1" colspan="1">Upper</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Age</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">17.063</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">25&#8211;40&#8201;years</td><td align="center" valign="top" rowspan="1" colspan="1">1.483</td><td align="center" valign="top" rowspan="1" colspan="1">0.379</td><td align="center" valign="top" rowspan="1" colspan="1">15.274</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.00</td><td align="center" valign="top" rowspan="1" colspan="1">4.406</td><td align="center" valign="top" rowspan="1" colspan="1">2.094</td><td align="center" valign="top" rowspan="1" colspan="1">9.268</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">41&#8211;50&#8201;years</td><td align="center" valign="top" rowspan="1" colspan="1">1.552</td><td align="center" valign="top" rowspan="1" colspan="1">0.409</td><td align="center" valign="top" rowspan="1" colspan="1">14.403</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.00</td><td align="center" valign="top" rowspan="1" colspan="1">4.721</td><td align="center" valign="top" rowspan="1" colspan="1">2.118</td><td align="center" valign="top" rowspan="1" colspan="1">10.523</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Above 50&#8201;years</td><td align="center" valign="top" rowspan="1" colspan="1">1.222</td><td align="center" valign="top" rowspan="1" colspan="1">0.449</td><td align="center" valign="top" rowspan="1" colspan="1">7.394</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.007</td><td align="center" valign="top" rowspan="1" colspan="1">3.393</td><td align="center" valign="top" rowspan="1" colspan="1">1.407</td><td align="center" valign="top" rowspan="1" colspan="1">8.185</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Education</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">11.685</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">0.02</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Primary</td><td align="center" valign="top" rowspan="1" colspan="1">0.838</td><td align="center" valign="top" rowspan="1" colspan="1">0.373</td><td align="center" valign="top" rowspan="1" colspan="1">5.057</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.02</td><td align="center" valign="top" rowspan="1" colspan="1">2.313</td><td align="center" valign="top" rowspan="1" colspan="1">1.114</td><td align="center" valign="top" rowspan="1" colspan="1">4.803</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Household contact</td><td align="center" valign="top" rowspan="1" colspan="1">0.699</td><td align="center" valign="top" rowspan="1" colspan="1">0.33</td><td align="center" valign="top" rowspan="1" colspan="1">4.49</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.034</td><td align="center" valign="top" rowspan="1" colspan="1">2.013</td><td align="center" valign="top" rowspan="1" colspan="1">1.054</td><td align="center" valign="top" rowspan="1" colspan="1">3.844</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Surgery</td><td align="center" valign="top" rowspan="1" colspan="1">0.502</td><td align="center" valign="top" rowspan="1" colspan="1">0.214</td><td align="center" valign="top" rowspan="1" colspan="1">5.503</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.019</td><td align="center" valign="top" rowspan="1" colspan="1">1.653</td><td align="center" valign="top" rowspan="1" colspan="1">1.086</td><td align="center" valign="top" rowspan="1" colspan="1">2.514</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Vaccination</td><td align="center" valign="top" rowspan="1" colspan="1">0.846</td><td align="center" valign="top" rowspan="1" colspan="1">0.257</td><td align="center" valign="top" rowspan="1" colspan="1">10.814</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.001</td><td align="center" valign="top" rowspan="1" colspan="1">2.331</td><td align="center" valign="top" rowspan="1" colspan="1">1.408</td><td align="center" valign="top" rowspan="1" colspan="1">3.859</td></tr></tbody></table><table-wrap-foot><p>Reference category was chosen to be 1st. Sig., Significant values (<italic toggle="yes">p</italic>-values&#8201;&lt;&#8201;0.05); <sup>a</sup>df, Degree of freedom; <sup>b</sup> AOR, Adjusted odd ratio.</p></table-wrap-foot></table-wrap></sec><sec id="sec28"><label>3.7</label><title>Lifestyle quality assessment of hepatitis-positive participants</title><p>The evaluation of quality lifestyle habits reveals that 50% of hepatitis-positive students and 40% of hepatitis-positive employees used to do exercise on a daily basis. Studying the food type prevalence, we observed normal food eaters represent high frequency in both the studied groups, i.e., 75% in hepatitis-positive students, 69% in hepatitis-negative students, 84% in hepatitis-positive employees, and 76% in hepatitis-negative employees in comparison to vegetarian, fast food, and meat eaters. Many hepatitis-positive participants, students (27%) and employees (57%), were noted to not go outdoor dining. A total of 36% of hepatitis-positive students, 45% of hepatitis-negative students, 36% of hepatitis-positive employees, and 39% of hepatitis-negative employees were spotted to be in the habit of eating fruits sliced by shopkeepers. The frequency of using filtered water in hepatitis-positive participants was noticed to be 51% (students) and 44% (employees). Studying the hygiene-related factors, it was observed that among hepatitis-positive participants 17% of students and 19% of employees did not wash their hands before eating, while in hepatitis-negative participants, 15% of students and 17% of employees did the same (<xref rid="SM1" ref-type="supplementary-material">Supplementary Table S8</xref>).</p></sec></sec><sec sec-type="discussion" id="sec29"><label>4</label><title>Discussion</title><p>Hepatitis is a contagious viral disease and different environmental and behavioral risk factors are known to contribute to its spread (<xref rid="ref24" ref-type="bibr">24</xref>). The current study was conducted to monitor the prevalence and association of possible risk factors of hepatitis among studied students and employees. Our findings revealed that, among studied participants, HCV is more prevalent than HBV. A very small percentage of students suffered from both HCV and HBV infection. A previous study conducted in Sindh, Pakistan reported higher frequency (14.3%) of HCV than HBV (14.3%) (<xref rid="ref15" ref-type="bibr">15</xref>). Another study reported a higher HCV prevalence (42.7%) than HBV (8.4%) in Punjab, Pakistan (<xref rid="ref25" ref-type="bibr">25</xref>). A high frequency of 9.9% of HBV in comparison to 4.1% of HCV was noted in the Taiwan population (<xref rid="ref26" ref-type="bibr">26</xref>).</p><p>A high prevalence of HBV was reported among male students and employees; among female students and employees, HCV was more prevalent, but an association was found with males as they were more at risk of suffering from hepatitis by a factor of 2.102. These findings were in agreement with an earlier study of Pakistan representing men to be more likely to suffer from hepatitis B, increasing its chance over 2.1 times, while women were 1.3 times more at risk of having HCV (<xref rid="ref25" ref-type="bibr">25</xref>). In a previous study in the USA, male sex was indicated as a risk factor for hepatitis C with an odd ratio of 1.25 (95% CI 1.03, 1.51) (<xref rid="ref27" ref-type="bibr">27</xref>). In our study, the independent association of hepatitis strain with any risk factor was not determined but overall our findings suggest that hepatitis was seen to be prevalent in the 16&#8211;25&#8201;years&#8217; age group in students and in the 26&#8211;40&#8201;year age group in employees, which was in agreement with a previous survey that also shows HBV is more frequent in the age group of 16&#8211;30&#8201;years, while HCV was noted to be more prevalent in patients above 61&#8201;years (<xref rid="ref25" ref-type="bibr">25</xref>). Age was noted to be associated with hepatitis among the employee group. Independent variable analysis of employees showed that the age group 25&#8211;40&#8201;years increases the likelihood of hepatitis by 4.406 factors. Similarly, the increase in age to 41&#8211;50&#8201;years also elevates the hepatitis risk by 4.721, and age above 50 contributed to an increase in its risk by 3.39 degrees. Our results were in agreement with a previous report suggesting an increase in age to be [OR 1.26 (95% CI 1.23, 1.30)] related to hepatitis (<xref rid="ref27" ref-type="bibr">27</xref>). Khan et al. indicated increasing age as a risk factor for HBV and HCV with a respective odd ratio of 4.2 and 56.5. These findings suggested that, with increasing age, the chance of developing hepatitis will be increased, and more precautions are required for prevention. It was observed that, in students, hepatitis was more prevalent in graduates while in employees its rate of occurrence decreases with an increase in the literacy level as only the employees educated to a primary level were found to be hepatitis positive. But no independent education variable was found to be associated with hepatitis in student groups. A previous survey mentioned a high prevalence of HCV in men with a primary education and graduates (<xref rid="ref24" ref-type="bibr">24</xref>). According to a previous study in Pakistan, no association with education was observed (<xref rid="ref10" ref-type="bibr">10</xref>). Social status was also noted, showing that its frequency was high in students and employees belonging to middle-class and low-earning families and contributed to hepatitis prevalence. In students, low income increases the hepatitis likelihood by an extent of 0.710. High income decreases its risk by 0.506 but no association was noted in hepatitis-positive participants (employee) and an independent income variable. Previously, unemployment was described to be correlated with HCV prevalence, which supports our result (<xref rid="ref28" ref-type="bibr">28</xref>). Here, literacy shows a link with hepatitis as education provides knowledge about the disease and in Pakistan high prevalence of the disease is majorly due to illiteracy and unemployment. The percentage of married students and employees was low, with a high frequency of intrafamily marriage, and they were less likely to be exposed to hepatitis infection by 4.51 factors. High frequency (46.7%) of HCV in a single individual was also reported earlier (<xref rid="ref24" ref-type="bibr">24</xref>). It was observed that, as compared to hepatitis negative-participants, a high percentage of household contacts was reported by hepatitis- positive participants, showing that hepatitis is a contagious disease and spread by contact with other members and was also found to be associated with hepatitis by <italic toggle="yes">X</italic><sup>2</sup> test. It was noted that, in employees, the hepatitis risk increases 2.01 times due to household contact. In our study, a very small frequency of infected mothers of hepatitis positive participants was noted, which shows that in our population mother-to-child transmission of infection is not common.</p><p>Several medical-related risk factors were also noted to be linked with hepatitis. In the present study, it was seen that students and employees who were vaccinated against hepatitis have a higher frequency of infection in comparison to hepatitis-negative participants. No association between hepatitis, blood group, and blood transfusion was noted, and their prevalence was more in the hepatitis-negative participants. Previously, contradictions were noticed in studies exploring the role of blood groups as hepatitis risk factors. In Pakistan, in an earlier study, association of blood group A with HBV was noted. Moreover, blood group O was reported to be protective against HBV (<xref rid="ref29" ref-type="bibr">29</xref>). In 2021, a study conducted in Multan, Pakistan reported blood group O to be a risk factor for HCV (<xref rid="ref30" ref-type="bibr">30</xref>). Further meta-analysis demonstrated a lower likelihood of HBV in blood group B individuals (<xref rid="ref31" ref-type="bibr">31</xref>). Formerly, blood transfusion frequency was also noted to be higher in the hepatitis-negative participants but was found to be a risk factor for HBV with an odd ratio of 7.03 (CI&#8201;=&#8201;3.37&#8211;14.66) and HCV with 14.88 (CI&#8201;=&#8201;8.14&#8211;27.16) odd ratio (<xref rid="ref15" ref-type="bibr">15</xref>). In Georgia, blood transfusion was considered as (AOR&#8201;=&#8201;4.5, 95% CI&#8201;=&#8201;2.8, 7.2) a HCV risk factor (<xref rid="ref28" ref-type="bibr">28</xref>). In comparison to hepatitis-negative students, hepatitis-positive students were observed to have facial treatments, which was found to be not associated as shown by the <italic toggle="yes">X</italic><sup>2</sup> test, but it was found to be less likely linked with hepatitis by 0.525 factors. Dental treatment frequency was higher in hepatitis-positive employees in contrast to the hepatitis-negative participants. By the logistic model, the significant independent association of dental treatment was recorded to be 0.744, indicating that students having dental treatment were less likely to have hepatitis than those without treatment. Hepatitis-positive participants represent a higher percentage of surgery than hepatitis-negative participants and were significantly associated with hepatitis as reported by the <italic toggle="yes">X</italic><sup>2</sup> test. These results were similar to the previous one where surgery and dental treatment were described to be associated with hepatitis by a respective odd factor of 2.7 and 4.1 (<xref rid="ref10" ref-type="bibr">10</xref>). An earlier study stated surgery and dental treatment as not being hepatitis risk factors (<xref rid="ref24" ref-type="bibr">24</xref>). Facial treatment was found to be less likely to be associated with hepatitis by a factor of 5.32 in the student group as its frequency was noted to be higher among hepatitis-negative participants. We have not found any intravenous drug abuse among our participants, however addiction to other orally taken drugs was noted to be significant among hepatitis-positive student participants. The association of vaccination and hepatitis was found with more likelihood (1.87) of hepatitis in vaccinated students and employees (2.31). These are the controversial results as a decline in HBV was narrated by the use of vaccination in China (<xref rid="ref32" ref-type="bibr">32</xref>). A high percentage of infection in already vaccinated hepatitis-positive participants might be due to the immunosuppressant participants, as hepatitis vaccines are known internationally to lower the infection risk.</p><p>Various kinds of behavioral-related factors were evaluated in the present study and found to be associated with hepatitis. Smoking frequency did not vary much among hepatitis-positive and -negative participants and was found not to be a hepatitis risk factor. A previous study also described smoking to not be related to chronic hepatitis B (<xref rid="ref33" ref-type="bibr">33</xref>). In our study, utilization of used syringes was found to be associated with hepatitis by <italic toggle="yes">X</italic><sup>2</sup>-test but its independent association with hepatitis cannot be recorded by logistic regression analysis. However, previous research conducted in Pakistan showed reused syringes to be a hepatitis risk factor (<xref rid="ref34" ref-type="bibr">34</xref>). Hygiene is the main factor to be considered to avoid contracting the hepatitis virus. Exploration of personal hygiene-related factors depicted the association of hepatitis with two factors: sharing shaving razors and machines. The frequency of sharing shaving blades was higher in the hepatitis-positive participants and is reported to increase the hepatitis risk by 1.41 factors in students sharing their shaving razors and machines. In earlier studies, shaving at a barber was found to be a hepatitis risk factor in Pakistan (<xref rid="ref25" ref-type="bibr">25</xref>). As the cosmetic sharing percentage was higher in hepatitis-negative participants, it was found to be negatively linked with hepatitis by a factor of 0.547. This indicates that unhygienic measurements can be considered a way for hepatitis to spread.</p><p>Further assessment of the quality of lifestyle done by comparing the lifestyle-related factors among hepatitis-positive and -negative participants depicted that the studied hepatitis-positive participants have adopted a healthy lifestyle which will be necessary to reduce further damage to the liver and the progression of infection. It was observed that, in the study participants, a large number of hepatitis-positive participants have a habit of exercising, eating normal food, avoiding outside dining, and using filtered water. All these factors are required for combating infection. These will also help in preventing exposure to other hepatitis strains. The only drawback is that the hepatitis-positive participants did not care about proper hand washing, which is crucial, as hand washing is helpful in preventing the spread of infection.</p><p>Although this study has proven to be successful in making IUB the first hepatitis-free university, certain limitations were there in exploring the information regarding the prevalence and hepatitis-associated factors. This research was limited to IUB students and employees and did not target any specific ethnic group or population of a specific province or district. Therefore, this is generalized research and does not define the association of hepatitis risk factors with any specific ethnic group or population of a specific province or district of the country.</p></sec><sec sec-type="conclusions" id="sec30"><label>5</label><title>Conclusion</title><p>Many hepatitis-related risk factors have been explored by the described research and can help design preventive strategies for hepatitis. We have recognized that socioeconomic parameters, medical-related factors, and behavioral measures are associated with a high prevalence of hepatitis in both students and employees. As the lifestyle of students differs from employees, risk factors association also varied accordingly. An ample understanding of risk factors can pave the way for better screening and prevention measurements as hepatitis is a preventable disease. The effective implementation of this awareness, screening, and vaccination program conferred IUB the status of Pakistan&#8217;s first Hepatitis-free university and, to continue this project (to keep IUB hepatitis-free), hepatitis screening and vaccination has been made compulsory for every admitted student. To ensure the successful implementation of the vaccination facility, the hepatitis vaccination center has been established in the IUB medical division. In the future, the identified risk factors will help raise awareness about hepatitis and reduce its prevalence in the Pakistani population. This study has provided general guidelines to be followed for other institutions and organizations, in Pakistan and abroad, to make them hepatitis-free in particular or any other infectious disease in general.</p></sec><sec sec-type="data-availability" id="sec31"><title>Data availability statement</title><p>The original contributions presented in the study are included in the article/<xref rid="SM1" ref-type="supplementary-material">Supplementary material</xref>, further inquiries can be directed to the corresponding author.</p></sec><sec sec-type="ethics-statement" id="sec32"><title>Ethics statement</title><p>The studies involving humans were approved by Hepatitis Control Program Core Committee, The Islamia University of Bahawalpur, Pakistan. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.</p></sec><sec sec-type="author-contributions" id="sec33"><title>Author contributions</title><p>SE: Conceptualization, Investigation, Project administration, Supervision, Validation, Writing &#8211; review &amp; editing. IA: Data curation, Formal analysis, Investigation, Methodology, Software, Validation, Writing &#8211; original draft. WM: Data curation, Formal analysis, Investigation, Methodology, Writing &#8211; original draft. SA: Project administration, Writing &#8211; review &amp; editing. MA: Project administration, Writing &#8211; review &amp; editing. NA: Conceptualization, Project administration. AK: Validation, Supervision. YH: Data curation, Writing &#8211; original draft. MU: Data-curation. UC: Supervision, Validation. SS: Project administration.</p></sec></body><back><ack><p>We are thankful to the Prof. Dr. Athar Mehboob, The Islamia University Bahawalpur (IUB), Health Department Government of Punjab, District Health Authority (DHA), Hepatitis Prevention and Control Program (HPCP), Government of Pakistan, and members of the organizing committee of the Hepatitis control program, IUB, Pakistan for their efforts to establish IUB as the first hepatitis-free University in Pakistan. We extend our gratitude toward the data collection team of BS Biochemistry 6th semester students, namely Ayyub Hassan, Muhammad Tahir, Muhammad Amjad, Muhammad Faraz, Baqa Ur Rehman, Muhammad Ameer Hamza Buzdar, Qurrat Ul Ain, Sana Noor, Maheen Rasheed, Urooj Mukhtar, Momna Jamil, and Arshia Ubaid (session 2017&#8211;2021) and BS Biochemistry 8th semester (session spring 2016&#8211;2020) students, namely Kashif Kareem, Aroma Tahir, Sarwat Batool, M. Yasir Bilal, Wajahat Ali, Jamshid Rafique, Nazish Rafique, Hina Ibraheem, Nimra Khan, Maryam Faryad, Aqsa Siddique, Sidra Falak, Sehrish Ijaz, Maham Khan, Bushra Gillani, Tayyaba Iqbal, Maria Anjum, Summra Firdous, Sana Hameed, Naila Noreen, Hafsa Saeed, and Sania Maryum. We are also thankful to the medical team and all the participants.</p></ack><fn-group><title>Abbreviations</title><fn fn-type="abbr"><p>IUB, The Islamia University Bahawalpur; HBV &amp; HCV, Hepatitis B and C virus; DHA, District Health Authority; HPCP, Hepatitis Prevention and Control Program; VC, Vice Chancellor; HBsAg, Surface antigen of the Hepatitis B virus; BVH, Bahawal Victoria Hospital; SPSS, Statistical Package for Social Science; X<sup>2</sup>, chi-square; CI, Confidence interval; ICT, Immunochromatographic test.</p></fn></fn-group><sec sec-type="COI-statement" id="sec35"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="disclaimer" id="sec100"><title>Publisher&#8217;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><sec sec-type="supplementary-material" id="sec36"><title>Supplementary material</title><p>The Supplementary material for this article can be found online at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.frontiersin.org/articles/10.3389/fpubh.2023.1269209/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fpubh.2023.1269209/full#supplementary-material</ext-link></p><supplementary-material id="SM1" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Table_1.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec><ref-list><title>References</title><ref id="ref1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stanaway</surname><given-names>JD</given-names></name><name name-style="western"><surname>Flaxman</surname><given-names>AD</given-names></name><name name-style="western"><surname>Naghavi</surname><given-names>M</given-names></name><name name-style="western"><surname>Fitzmaurice</surname><given-names>C</given-names></name><name name-style="western"><surname>Vos</surname><given-names>T</given-names></name><name name-style="western"><surname>Abubakar</surname><given-names>I</given-names></name><etal/></person-group>. <article-title>The global burden of viral hepatitis from 1990 to 2013: findings from the global burden of disease study 2013</article-title>. <source>Lancet</source>. (<year>2016</year>) <volume>388</volume>:<fpage>1081</fpage>&#8211;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0140-6736(16)30579-7</pub-id>, PMID: <pub-id pub-id-type="pmid">27394647</pub-id><pub-id pub-id-type="pmcid">PMC5100695</pub-id></mixed-citation></ref><ref id="ref2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blach</surname><given-names>S</given-names></name><name name-style="western"><surname>Kondili</surname><given-names>LA</given-names></name><name name-style="western"><surname>Aghemo</surname><given-names>A</given-names></name><name name-style="western"><surname>Cai</surname><given-names>Z</given-names></name><name name-style="western"><surname>Dugan</surname><given-names>E</given-names></name><name name-style="western"><surname>Estes</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Impact of COVID-19 on global HCV elimination efforts</article-title>. <source>J Hepatol</source>. (<year>2021</year>) <volume>74</volume>:<fpage>31</fpage>&#8211;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jhep.2020.07.042</pub-id>, PMID: <pub-id pub-id-type="pmid">32777322</pub-id><pub-id pub-id-type="pmcid">PMC7411379</pub-id></mixed-citation></ref><ref id="ref3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Si</surname><given-names>J</given-names></name><name name-style="western"><surname>Yu</surname><given-names>C</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Y</given-names></name><name name-style="western"><surname>Bian</surname><given-names>Z</given-names></name><name name-style="western"><surname>Meng</surname><given-names>R</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Chronic hepatitis B virus infection and total and cause-specific mortality: a prospective cohort study of 0.5 million people</article-title>. <source>BMJ Open</source>. (<year>2019</year>) <volume>9</volume>:<fpage>e027696</fpage>. doi: <pub-id pub-id-type="doi">10.1136/bmjopen-2018-027696</pub-id>, PMID: <pub-id pub-id-type="pmid">30967410</pub-id><pub-id pub-id-type="pmcid">PMC6500223</pub-id></mixed-citation></ref><ref id="ref4"><label>4.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Sung</surname><given-names>M-H</given-names></name></person-group>. <source>Studies of hepatitis B virus and hepatitis C virus infection</source>. <publisher-loc>Los Angeles, CA</publisher-loc>: <publisher-name>University of Southern California</publisher-name> (<year>2002</year>).</mixed-citation></ref><ref id="ref5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goldstein</surname><given-names>ST</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>F</given-names></name><name name-style="western"><surname>Hadler</surname><given-names>SC</given-names></name><name name-style="western"><surname>Bell</surname><given-names>BP</given-names></name><name name-style="western"><surname>Mast</surname><given-names>EE</given-names></name><name name-style="western"><surname>Margolis</surname><given-names>HS</given-names></name></person-group>. <article-title>A mathematical model to estimate global hepatitis B disease burden and vaccination impact</article-title>. <source>Int J Epidemiol</source>. (<year>2005</year>) <volume>34</volume>:<fpage>1329</fpage>&#8211;<lpage>39</lpage>. doi: <pub-id pub-id-type="doi">10.1093/ije/dyi206</pub-id>, PMID: <pub-id pub-id-type="pmid">16249217</pub-id></mixed-citation></ref><ref id="ref6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maqsood</surname><given-names>S</given-names></name><name name-style="western"><surname>Iqbal</surname><given-names>S</given-names></name><name name-style="western"><surname>Zakar</surname><given-names>R</given-names></name><name name-style="western"><surname>Zakar</surname><given-names>MZ</given-names></name><name name-style="western"><surname>Fischer</surname><given-names>F</given-names></name></person-group>. <article-title>Determinants of overall knowledge and health behaviours in relation to hepatitis B and C among ever-married women in Pakistan: evidence based on demographic and health survey 2017&#8211;18</article-title>. <source>BMC Public Health</source>. (<year>2021</year>) <volume>21</volume>:<fpage>1</fpage>&#8211;<lpage>13</lpage>. doi: <pub-id pub-id-type="doi">10.1186/s12889-021-12406-z</pub-id><pub-id pub-id-type="pmid">34969379</pub-id><pub-id pub-id-type="pmcid">PMC8719411</pub-id></mixed-citation></ref><ref id="ref7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oon</surname><given-names>GC</given-names></name></person-group>. <article-title>Viral hepatitis&#8212;the silent killer</article-title>. <source>Ann Acad Med Singapore</source>. (<year>2012</year>) <volume>41</volume>:<fpage>279</fpage>&#8211;<lpage>80</lpage>. doi: <pub-id pub-id-type="doi">10.47102/annals-acadmedsg.V41N7p279</pub-id>, PMID: <pub-id pub-id-type="pmid">22892603</pub-id></mixed-citation></ref><ref id="ref8"><label>8.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab id="coll1">WHO</collab></person-group>. <source>Hepatitis B</source>. (<year>2023</year>). <publisher-name>World Health Organization</publisher-name>.</mixed-citation></ref><ref id="ref9"><label>9.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab id="coll2">WHO</collab></person-group>. <source>Hepatitis C</source>. (<year>2023</year>). <publisher-name>World Health Organization</publisher-name>.</mixed-citation></ref><ref id="ref10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shafiq</surname><given-names>M</given-names></name><name name-style="western"><surname>Nadeem</surname><given-names>M</given-names></name><name name-style="western"><surname>Sattar</surname><given-names>Z</given-names></name><name name-style="western"><surname>Khan</surname><given-names>SM</given-names></name><name name-style="western"><surname>Faheem</surname><given-names>SM</given-names></name><name name-style="western"><surname>Ahsan</surname><given-names>I</given-names></name><etal/></person-group>. <article-title>Identification of risk factors for hepatitis B and C in Peshawar, Pakistan</article-title>. <source>HIV/AIDS</source>. (<year>2015</year>) <volume>7</volume>:<fpage>223</fpage>&#8211;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.2147/hiv.S67429</pub-id>, PMID: <pub-id pub-id-type="pmid">26316823</pub-id><pub-id pub-id-type="pmcid">PMC4544815</pub-id></mixed-citation></ref><ref id="ref11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kao</surname><given-names>JH</given-names></name><name name-style="western"><surname>Chen</surname><given-names>DS</given-names></name></person-group>. <article-title>Transmission of hepatitis C virus in Asia: past and present perspectives</article-title>. <source>J Gastroenterol Hepatol</source>. (<year>2000</year>) <volume>15</volume>:<fpage>E91</fpage>&#8211;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1046/j.1440-1746.2000.02108.x</pub-id> PMID: <pub-id pub-id-type="pmid">10921389</pub-id></mixed-citation></ref><ref id="ref12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Madihi</surname><given-names>S</given-names></name><name name-style="western"><surname>Syed</surname><given-names>H</given-names></name><name name-style="western"><surname>Lazar</surname><given-names>F</given-names></name><name name-style="western"><surname>Zyad</surname><given-names>A</given-names></name><name name-style="western"><surname>Benani</surname><given-names>A</given-names></name></person-group>. <article-title>A systematic review of the current hepatitis B viral infection and hepatocellular carcinoma situation in Mediterranean countries</article-title>. <source>Biomed Res Int</source>. (<year>2020</year>) <volume>2020</volume>:<fpage>1</fpage>&#8211;<lpage>16</lpage>. doi: <pub-id pub-id-type="doi">10.1155/2020/7027169</pub-id>, PMID: <pub-id pub-id-type="pmid">32626758</pub-id><pub-id pub-id-type="pmcid">PMC7305551</pub-id></mixed-citation></ref><ref id="ref13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seerat</surname><given-names>I</given-names></name><name name-style="western"><surname>Mushtaq</surname><given-names>H</given-names></name><name name-style="western"><surname>Rafiq</surname><given-names>M</given-names></name><name name-style="western"><surname>Nadir</surname><given-names>A</given-names></name></person-group>. <article-title>Frequency and associated risk factors of hepatitis B virus and hepatitis C virus infections in children at a hepatitis prevention and treatment Clinic in Lahore, Pakistan</article-title>. <source>Cureus</source>. (<year>2020</year>) <volume>12</volume>:<fpage>e7926</fpage>. doi: <pub-id pub-id-type="doi">10.7759/cureus.7926</pub-id>, PMID: <pub-id pub-id-type="pmid">32494536</pub-id><pub-id pub-id-type="pmcid">PMC7265754</pub-id></mixed-citation></ref><ref id="ref14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Waheed</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shafi</surname><given-names>T</given-names></name><name name-style="western"><surname>Safi</surname><given-names>SZ</given-names></name><name name-style="western"><surname>Qadri</surname><given-names>I</given-names></name></person-group>. <article-title>Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors</article-title>. <source>World J Gastroenterol</source>. (<year>2009</year>) <volume>15</volume>:<fpage>5647</fpage>&#8211;<lpage>53</lpage>. doi: <pub-id pub-id-type="doi">10.3748/wjg.15.5647</pub-id>, PMID: <pub-id pub-id-type="pmid">19960560</pub-id><pub-id pub-id-type="pmcid">PMC2789216</pub-id></mixed-citation></ref><ref id="ref15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Samo</surname><given-names>AA</given-names></name><name name-style="western"><surname>Laghari</surname><given-names>ZA</given-names></name><name name-style="western"><surname>Baig</surname><given-names>NM</given-names></name><name name-style="western"><surname>Khoso</surname><given-names>GM</given-names></name></person-group>. <article-title>Prevalence and risk factors associated with hepatitis B and C in Nawabshah, Sindh, Pakistan</article-title>. <source>Am J Trop Med Hygiene</source>. (<year>2020</year>) <volume>104</volume>:<fpage>1101</fpage>&#8211;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.4269/ajtmh.20-1228</pub-id>, PMID: <pub-id pub-id-type="pmid">33350368</pub-id><pub-id pub-id-type="pmcid">PMC7941847</pub-id></mixed-citation></ref><ref id="ref16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williams</surname><given-names>IT</given-names></name><name name-style="western"><surname>Bell</surname><given-names>BP</given-names></name><name name-style="western"><surname>Kuhnert</surname><given-names>W</given-names></name><name name-style="western"><surname>Alter</surname><given-names>MJ</given-names></name></person-group>. <article-title>Incidence and transmission patterns of acute hepatitis C in the United States, 1982-2006</article-title>. <source>Arch Intern Med</source>. (<year>2011</year>) <volume>171</volume>:<fpage>242</fpage>&#8211;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1001/archinternmed.2010.511</pub-id><pub-id pub-id-type="pmid">21325115</pub-id></mixed-citation></ref><ref id="ref17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hajarizadeh</surname><given-names>B</given-names></name><name name-style="western"><surname>Grebely</surname><given-names>J</given-names></name><name name-style="western"><surname>Dore</surname><given-names>GJ</given-names></name></person-group>. <article-title>Epidemiology and natural history of HCV infection</article-title>. <source>Nat Rev Gastroenterol Hepatol</source>. (<year>2013</year>) <volume>10</volume>:<fpage>553</fpage>&#8211;<lpage>62</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrgastro.2013.107</pub-id><pub-id pub-id-type="pmid">23817321</pub-id></mixed-citation></ref><ref id="ref18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Butt</surname><given-names>AS</given-names></name><name name-style="western"><surname>Sharif</surname><given-names>F</given-names></name></person-group>. <article-title>Viral hepatitis in Pakistan: past, present, and future</article-title>. <source>Eur J Hepato-Gastroenterol</source>. (<year>2016</year>) <volume>6</volume>:<fpage>70</fpage>&#8211;<lpage>81</lpage>. doi: <pub-id pub-id-type="doi">10.5005/jp-journals-10018-1172</pub-id>, PMID: <pub-id pub-id-type="pmid">29201731</pub-id><pub-id pub-id-type="pmcid">PMC5578565</pub-id></mixed-citation></ref><ref id="ref19"><label>19.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Bauman</surname><given-names>Z</given-names></name></person-group>. <source>The individualized society</source>. <publisher-loc>Polity press, Cambridge</publisher-loc>: <publisher-name>John Wiley &amp; Sons</publisher-name> (<year>2013</year>).</mixed-citation></ref><ref id="ref20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bennasar-Veny</surname><given-names>M</given-names></name><name name-style="western"><surname>Ya&#241;ez</surname><given-names>AM</given-names></name><name name-style="western"><surname>Pericas</surname><given-names>J</given-names></name><name name-style="western"><surname>Ballester</surname><given-names>L</given-names></name><name name-style="western"><surname>Fernandez-Dominguez</surname><given-names>JC</given-names></name><name name-style="western"><surname>Tauler</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Cluster analysis of health-related lifestyles in university students</article-title>. <source>Int J Environ Res Public Health</source>. (<year>2020</year>) <volume>17</volume>:<fpage>1776</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijerph17051776</pub-id><pub-id pub-id-type="pmid">32182922</pub-id><pub-id pub-id-type="pmcid">PMC7084566</pub-id></mixed-citation></ref><ref id="ref21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ali</surname><given-names>M</given-names></name><name name-style="western"><surname>Imtiaz</surname><given-names>F</given-names></name><name name-style="western"><surname>Khan</surname><given-names>MAR</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>B</given-names></name><name name-style="western"><surname>Umer</surname><given-names>M</given-names></name><name name-style="western"><surname>Akhtar</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Hepatitis B virus and undergraduate students: a study on levels of awareness in universities across Karachi</article-title>. <source>Pak J Public Health</source>. (<year>2018</year>) <volume>8</volume>:<fpage>75</fpage>&#8211;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.32413/pjph.v8i2.126</pub-id></mixed-citation></ref><ref id="ref22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ibrahim</surname><given-names>N</given-names></name><name name-style="western"><surname>Idris</surname><given-names>A</given-names></name></person-group>. <article-title>Hepatitis B awareness among medical students and their vaccination status at Syrian private university</article-title>. <source>Hepat Res Treat</source>. <volume>2014</volume>:<fpage>131920</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2014/131920</pub-id>, PMID: <pub-id pub-id-type="pmid">25478218</pub-id><pub-id pub-id-type="pmcid">PMC4244916</pub-id></mixed-citation></ref><ref id="ref23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Poordad</surname><given-names>F</given-names></name><name name-style="western"><surname>Reddy</surname><given-names>KR</given-names></name><name name-style="western"><surname>Martin</surname><given-names>P</given-names></name></person-group>. <article-title>Rapid virologic response: a new milestone in the management of chronic hepatitis C</article-title>. <source>Clin Infect Dis</source>. (<year>2008</year>) <volume>46</volume>:<fpage>78</fpage>&#8211;<lpage>84</lpage>. doi: <pub-id pub-id-type="doi">10.1086/523585</pub-id>, PMID: <pub-id pub-id-type="pmid">18171217</pub-id></mixed-citation></ref><ref id="ref24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mokhtari</surname><given-names>M</given-names></name><name name-style="western"><surname>Basirkazeruni</surname><given-names>H</given-names></name><name name-style="western"><surname>Rostami</surname><given-names>M</given-names></name></person-group>. <article-title>The correlation between different risk factors of hepatitis C and different genotypes</article-title>. <source>Adv Biomed Res</source>. (<year>2017</year>) <volume>6</volume>:<fpage>45</fpage>. doi: <pub-id pub-id-type="doi">10.4103/2277-9175.204588</pub-id><pub-id pub-id-type="pmid">28503500</pub-id><pub-id pub-id-type="pmcid">PMC5414405</pub-id></mixed-citation></ref><ref id="ref25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>A</given-names></name><name name-style="western"><surname>Afzal</surname><given-names>S</given-names></name><name name-style="western"><surname>Yaqoob</surname><given-names>A</given-names></name><name name-style="western"><surname>Fatima</surname><given-names>R</given-names></name><name name-style="western"><surname>Ul Haq</surname><given-names>M</given-names></name><name name-style="western"><surname>Junaid</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Epidemiology of viral hepatitis B and C in Punjab, Pakistan: a multicenter cross-sectional study, 2017-18 [version 1; peer review: 2 approved with reservations]</article-title>. <source>F1000Res</source>. (<year>2019</year>) <volume>8</volume>:<fpage>2065</fpage>. doi: <pub-id pub-id-type="doi">10.12688/f1000research.20174.1</pub-id></mixed-citation></ref><ref id="ref26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>W-C</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Y-C</given-names></name><name name-style="western"><surname>Chen</surname><given-names>P-J</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>N-T</given-names></name><name name-style="western"><surname>Tu</surname><given-names>C-L</given-names></name><name name-style="western"><surname>Chang</surname><given-names>T-S</given-names></name><etal/></person-group>. <article-title>Community-based screening for hepatitis B and C infectivity using two quantitative antigens to identify endemic townships</article-title>. <source>Viruses</source>. (<year>2022</year>) <volume>14</volume>:<fpage>304</fpage>. doi: <pub-id pub-id-type="doi">10.3390/v14020304</pub-id>, PMID: <pub-id pub-id-type="pmid">35215896</pub-id><pub-id pub-id-type="pmcid">PMC8879708</pub-id></mixed-citation></ref><ref id="ref27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ford</surname><given-names>JS</given-names></name><name name-style="western"><surname>Hollywood</surname><given-names>E</given-names></name><name name-style="western"><surname>Steuble</surname><given-names>B</given-names></name><name name-style="western"><surname>Meng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Voong</surname><given-names>S</given-names></name><name name-style="western"><surname>Chechi</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Risk factors for hepatitis C virus infection at a large urban emergency department</article-title>. <source>J Viral Hepat</source>. (<year>2022</year>) <volume>29</volume>:<fpage>930</fpage>&#8211;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1111/jvh.13730</pub-id>, PMID: <pub-id pub-id-type="pmid">35789152</pub-id></mixed-citation></ref><ref id="ref28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hagan</surname><given-names>LM</given-names></name><name name-style="western"><surname>Kasradze</surname><given-names>A</given-names></name><name name-style="western"><surname>Salyer</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Gamkrelidze</surname><given-names>A</given-names></name><name name-style="western"><surname>Alkhazashvili</surname><given-names>M</given-names></name><name name-style="western"><surname>Chanturia</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination</article-title>. <source>BMC Public Health</source>. (<year>2019</year>) <volume>19</volume>:<fpage>480</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12889-019-6784-3</pub-id><pub-id pub-id-type="pmid">32326913</pub-id><pub-id pub-id-type="pmcid">PMC6696670</pub-id></mixed-citation></ref><ref id="ref29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Batool</surname><given-names>Z</given-names></name><name name-style="western"><surname>Durrani</surname><given-names>SH</given-names></name><name name-style="western"><surname>Tariq</surname><given-names>S</given-names></name></person-group>. <article-title>Association of abo and Rh blood group types to hepatitis B, hepatitis C, HIV and syphilis infection, a five year&#8217; experience in healthy blood donors in a tertiary care hospital</article-title>. <source>J Ayub Med Coll Abbottabad</source>. (<year>2017</year>) <volume>29</volume>:<fpage>90</fpage>&#8211;<lpage>2</lpage>.<pub-id pub-id-type="pmid">28712183</pub-id></mixed-citation></ref><ref id="ref30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahnoor</surname><given-names>NM</given-names></name><name name-style="western"><surname>Imran</surname><given-names>M</given-names></name><name name-style="western"><surname>Safi</surname><given-names>SZ</given-names></name><name name-style="western"><surname>Bashir</surname><given-names>MA</given-names></name><name name-style="western"><surname>Alkhuriji</surname><given-names>AF</given-names></name><name name-style="western"><surname>Alomar</surname><given-names>SY</given-names></name><etal/></person-group>. <article-title>Association of blood groups with hepatitis C viremia</article-title>. <source>Saudi J Biol Sci</source>. (<year>2021</year>) <volume>28</volume>:<fpage>5359</fpage>&#8211;<lpage>63</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.sjbs.2021.05.062</pub-id>, PMID: <pub-id pub-id-type="pmid">34466115</pub-id><pub-id pub-id-type="pmcid">PMC8381043</pub-id></mixed-citation></ref><ref id="ref31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jing</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>S</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M</given-names></name></person-group>. <article-title>ABO blood groups and hepatitis B virus infection: a systematic review and meta-analysis</article-title>. <source>BMJ Open</source>. (<year>2020</year>) <volume>10</volume>:<fpage>e034114</fpage>. doi: <pub-id pub-id-type="doi">10.1136/bmjopen-2019-034114</pub-id>, PMID: <pub-id pub-id-type="pmid">32014878</pub-id><pub-id pub-id-type="pmcid">PMC7045238</pub-id></mixed-citation></ref><ref id="ref32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Tao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>J</given-names></name><name name-style="western"><surname>Yan</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Epidemiological study of hepatitis B and hepatitis C infections in Northeastern China and the beneficial effect of the vaccination strategy for hepatitis B: a cross-sectional study</article-title>. <source>BMC Public Health</source>. (<year>2018</year>) <volume>18</volume>:<fpage>1088</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12889-018-5984-6</pub-id>, PMID: <pub-id pub-id-type="pmid">30176842</pub-id><pub-id pub-id-type="pmcid">PMC6122542</pub-id></mixed-citation></ref><ref id="ref33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hamilton</surname><given-names>E</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name><name name-style="western"><surname>Mentzer</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lv</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Conventional and genetic risk factors for chronic hepatitis B virus infection in a community-based study of 0.5 million Chinese adults</article-title>. <source>Sci Rep</source>. (<year>2022</year>) <volume>12</volume>:<fpage>12075</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-022-16360-7</pub-id>, PMID: <pub-id pub-id-type="pmid">35840665</pub-id><pub-id pub-id-type="pmcid">PMC9287541</pub-id></mixed-citation></ref><ref id="ref34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Awan</surname><given-names>ZUR</given-names></name><name name-style="western"><surname>Naveed</surname><given-names>J</given-names></name><name name-style="western"><surname>Mehboob</surname><given-names>URA</given-names></name></person-group>. <article-title>2. Hepatitis C virus (HCV) infection in general population of district Bannu Khyber Pakhtunkhwa, Pakistan</article-title>. <source>Pure Appl Biol</source>. (<year>2020</year>) <volume>3</volume>:<fpage>1679</fpage>&#8211;<lpage>89</lpage>. doi: <pub-id pub-id-type="doi">10.19045/bspab.2020.90178</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>